| Year |
Citation |
Score |
| 2023 |
Carson JL, Brooks MM, Hébert PC, Goodman SG, Bertolet M, Glynn SA, Chaitman BR, Simon T, Lopes RD, Goldsweig AM, DeFilippis AP, Abbott JD, Potter BJ, Carrier FM, Rao SV, ... ... White HD, et al. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. The New England Journal of Medicine. PMID 37952133 DOI: 10.1056/NEJMoa2307983 |
0.314 |
|
| 2023 |
Stone GW, Ali ZA, O'Brien SM, Rhodes G, Genereux P, Bangalore S, Mavromatis K, Horst J, Dressler O, Poh KK, Nath RK, Moorthy N, Witkowski A, Dwivedi SK, Bockeria O, ... ... White HD, et al. Impact of Complete Revascularization in the ISCHEMIA Trial. Journal of the American College of Cardiology. PMID 37462593 DOI: 10.1016/j.jacc.2023.06.015 |
0.33 |
|
| 2023 |
Steg PG, Szarek M, Valgimigli M, Islam S, Zeiher AM, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Goodman SG, Gotcheva N, Harrington RA, Jukema JW, Kim HS, Kim SH, ... ... White HD, et al. Lipoprotein(a) and the Effect of Alirocumab on Revascularization Following Acute Coronary Syndrome. The Canadian Journal of Cardiology. PMID 37116789 DOI: 10.1016/j.cjca.2023.04.018 |
0.357 |
|
| 2022 |
Chiang CE, Schwartz GG, Elbez Y, Szarek M, Bhatt DL, Bittner VA, Diaz R, Erglis A, Goodman SG, Hagström E, Jukema JW, Liberopoulos E, Loy M, Pordy R, White HD, et al. Alirocumab and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: Prespecified Sub-analysis from ODYSSEY OUTCOMES. The Canadian Journal of Cardiology. PMID 35644332 DOI: 10.1016/j.cjca.2022.05.021 |
0.405 |
|
| 2022 |
Lopes RD, Guimarães PO, Schwartz GG, Bhatt DL, Bittner VA, Budaj A, Dalby AJ, Diaz R, Goodman SG, Harrington RA, Jukema JW, Kiss RG, Loy M, Pordy R, Poulouin Y, ... ... White HD, et al. Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Randomized Trial. The American Journal of Medicine. PMID 35296402 DOI: 10.1016/j.amjmed.2022.02.016 |
0.307 |
|
| 2022 |
Tan S, White HD, Layland J. Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based? European Heart Journal. PMID 35048118 DOI: 10.1093/eurheartj/ehab896 |
0.313 |
|
| 2021 |
Cavender MA, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX. Circulation. Cardiovascular Interventions. CIRCINTERVENTIONS120. PMID 34915723 DOI: 10.1161/CIRCINTERVENTIONS.120.010390 |
0.317 |
|
| 2021 |
White HD, Steg PG, Schwartz GG. Myocardial Infarction and Evolocumab. Jama Cardiology. PMID 34160548 DOI: 10.1001/jamacardio.2021.1994 |
0.308 |
|
| 2021 |
Diaz R, Li QH, Bhatt DL, Bittner VA, Baccara-Dinet MT, Goodman SG, Jukema JW, Kimura T, Parkhomenko A, Pordy R, Reiner Ž, Roe MT, Szarek M, Tse HF, White HD, et al. Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial. European Journal of Preventive Cardiology. 28: 33-43. PMID 33755145 DOI: 10.1177/2047487320941987 |
0.308 |
|
| 2021 |
Stewart RAH, Jones P, Dicker B, Jiang Y, Smith T, Swain A, Kerr A, Scott T, Smyth D, Ranchord A, Edmond J, Than M, Webster M, White HD, Devlin G. High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial. Bmj (Clinical Research Ed.). 372: n355. PMID 33653685 DOI: 10.1136/bmj.n355 |
0.31 |
|
| 2021 |
Ostadal P, Steg PG, Poulouin Y, Bhatt D, Bittner V, Chua T, Diaz R, Goodman S, Harrington R, Jukema JW, Karpov Y, Pordy R, Scemama M, Szarek M, White HD, et al. METABOLIC RISK FACTORS AND THE EFFECT OF ALIROCUMAB ON CARDIOVASCULAR EVENTS IN PATIENTS AFTER ACUTE CORONARY SYNDROME: AN ANALYSIS OF THE ODYSSEY OUTCOMES RANDOMIZED CONTROLLED TRIAL Journal of the American College of Cardiology. 77: 150. DOI: 10.1016/S0735-1097(21)01509-6 |
0.33 |
|
| 2020 |
Chan DZ, Stewart RA, Kerr AJ, Dicker B, Kyle CV, Adamson PD, Devlin G, Edmond J, El-Jack S, Elliott JM, Fisher N, Flynn C, Lee M, Liao YB, Rhodes M, ... ... White HD, et al. The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55). The Lancet Regional Health. Western Pacific. 5: 100056. PMID 34173604 DOI: 10.1016/j.lanwpc.2020.100056 |
0.301 |
|
| 2020 |
Chaitman BR, Alexander KP, Cyr DD, Berger JS, Reynolds HR, Bangalore S, Boden WE, Lopes RD, Demkow M, Perna GP, Riezebos RK, McFalls EO, Banerjee S, Bagai A, Gosselin G, ... ... White HD, et al. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation. PMID 33267610 DOI: 10.1161/CIRCULATIONAHA.120.047987 |
0.321 |
|
| 2020 |
Lee S, Miller R, Lee M, White H, Kerr A. Outcomes after ST-elevation myocardial infarction presentation to hospitals with or without a routine primary percutaneous coronary intervention service (ANZACS-QI 46). The New Zealand Medical Journal. 133: 64-81. PMID 33119571 |
0.336 |
|
| 2020 |
Marquis-Gravel G, Neely ML, Valgimigli M, Costa F, Van Klaveren D, Altner R, Bhatt DL, Armstrong PW, Fox KAA, White HD, Ohman EM, Roe MT. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization. Circulation. Cardiovascular Quality and Outcomes. CIRCOUTCOMES12000658. PMID 32862694 DOI: 10.1161/CIRCOUTCOMES.120.006582 |
0.383 |
|
| 2020 |
Diaz R, Li QH, Bhatt DL, Bittner VA, Baccara-Dinet MT, Goodman SG, Jukema JW, Kimura T, Parkhomenko A, Pordy R, Reiner Ž, Roe MT, Szarek M, Tse HF, White HD, et al. Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial. European Journal of Preventive Cardiology. 2047487320941987. PMID 32718237 DOI: 10.1177/2047487320941987 |
0.308 |
|
| 2020 |
Marquis-Gravel G, Dalgaard F, Jones AD, Lokhnygina Y, James SK, Harrington RA, Wallentin L, Steg PG, Lopes RD, Storey RF, Goodman SG, Mahaffey KW, Tricoci P, White HD, Armstrong PW, et al. Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI. Journal of the American College of Cardiology. 76: 162-171. PMID 32646565 DOI: 10.1016/J.Jacc.2020.05.031 |
0.356 |
|
| 2020 |
Wang TKM, Mehta OH, Liao YB, Wang MTM, Stewart R, White H. Meta-Analysis of Bleeding Scores Performance for Acute Coronary Syndrome. Heart, Lung & Circulation. PMID 32586729 DOI: 10.1016/j.hlc.2020.04.008 |
0.333 |
|
| 2020 |
White HD, Stewart RAH, Dalby AJ, Stebbins A, Cannon CP, Budaj A, Linhart A, Pais P, Diaz R, Steg PG, Krug-Gourley S, Granger CB, Hochman JS, Koenig W, Harrington RA, et al. In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events. American Heart Journal. 225: 97-107. PMID 32480059 DOI: 10.1016/J.Ahj.2020.04.004 |
0.323 |
|
| 2020 |
Bhatt DL, Briggs AH, Reed SD, Annemans L, Szarek M, Bittner VA, Diaz R, Goodman SG, Harrington RA, Higuchi K, Joulain F, Jukema JW, Li QH, Mahaffey KW, Sanchez RJ, ... ... White HD, et al. Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial. Journal of the American College of Cardiology. 75: 2297-2308. PMID 32381160 DOI: 10.1016/J.Jacc.2020.03.029 |
0.351 |
|
| 2020 |
Hilvo M, Wallentin L, Ghukasyan Lakic T, Held C, Kauhanen D, Jylhä A, Lindbäck J, Siegbahn A, Granger CB, Koenig W, Stewart RAH, White H, Laaksonen R. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy. Journal of the American Heart Association. e015258. PMID 32375553 DOI: 10.1161/JAHA.119.015258 |
0.308 |
|
| 2020 |
Kerr AJ, Mitnala S, Lee M, White HD. Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26). The New Zealand Medical Journal. 133: 21-40. PMID 32161419 |
0.322 |
|
| 2020 |
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Schwartz GG. Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. Journal of the American College of Cardiology. 75: 448-451. PMID 32000957 DOI: 10.1016/J.Jacc.2019.11.030 |
0.337 |
|
| 2020 |
Wong CK, White HD. Acute Myocardial Infarction: Fibrinolytic Therapy. Current Treatment Options in Cardiovascular Medicine. 6: 15-28. PMID 15023281 DOI: 10.1007/S11936-004-0011-X |
0.34 |
|
| 2020 |
Zahger D, Szarek M, Bhatt DL, Bittner VA, Budaj A, Diaz R, Goodman SG, Jukema JWW, Kiss RG, McGinniss J, Harrington RA, Moriarty PM, Pordy R, Reiner Z, Loy M, ... ... White HD, et al. Abstract 15281: Triglyceride Levels and Cardiovascular Outcomes After Acute Coronary Syndrome: Insights From the Odyssey Outcomes Trial Circulation. 142. DOI: 10.1161/CIRC.142.SUPPL_3.15281 |
0.326 |
|
| 2019 |
Szarek M, Steg PG, DiCenso D, Bhatt DL, Bittner VA, Budaj A, Diaz R, Goodman SG, Gotcheva N, Jukema JW, Pordy R, Roe MT, Sourdille T, White HD, Xavier D, et al. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial. Circulation. Cardiovascular Quality and Outcomes. 12: e005858. PMID 31707826 DOI: 10.1161/Circoutcomes.119.005858 |
0.333 |
|
| 2019 |
Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Harrington RA, Jukema JW, Kedev S, Letierce A, Moryusef A, Pordy R, ... ... White HD, et al. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery. Journal of the American College of Cardiology. 74: 1177-1186. PMID 31466614 DOI: 10.1016/J.Jacc.2019.07.015 |
0.34 |
|
| 2019 |
Olivier CB, Bhatt DL, Leonardi S, Stone GW, Gibson CM, Steg PG, Hamm CW, Wilson MD, Mangum S, Price MJ, Prats J, White HD, Lopes RD, Harrington RA, Mahaffey KW, et al. Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention. Circulation. Cardiovascular Interventions. 12: e007342. PMID 31296081 DOI: 10.1161/CIRCINTERVENTIONS.118.007342 |
0.371 |
|
| 2019 |
Kerr A, Lee M, Grey C, Pegg T, Fisher N, White H, Nunn C, Williams M, Smyth D, Scott T, Chen R, Zhao J, Tun TR, Harwood M, Devlin G. Acute reperfusion for ST-elevation myocardial infarction in New Zealand (2015-2017): patient and system delay (ANZACS-QI 29). The New Zealand Medical Journal. 132: 41-59. PMID 31295237 |
0.353 |
|
| 2019 |
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, ... ... White HD, et al. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. The Lancet. Diabetes & Endocrinology. PMID 31272931 DOI: 10.1016/S2213-8587(19)30158-5 |
0.323 |
|
| 2019 |
White HD, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Erglis A, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lopes RD, Mahaffey KW, Moryusef A, et al. Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. European Heart Journal. PMID 31121022 DOI: 10.1093/Eurheartj/Ehz299 |
0.341 |
|
| 2019 |
Steg PG, Szarek M, Bhatt DL, Bittner VA, Brégeault MF, Dalby AJ, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, ... ... White HD, et al. Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial. Circulation. PMID 31117810 DOI: 10.1161/Circulationaha.118.038840 |
0.345 |
|
| 2019 |
Jukema JW, Szarek M, Zijlstra LE, de Silva HA, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Karpov Y, Moryusef A, Pordy R, Prieto JC, ... ... White HD, et al. Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial. Journal of the American College of Cardiology. PMID 30898609 DOI: 10.1016/J.Jacc.2019.03.013 |
0.383 |
|
| 2019 |
Berwanger O, Lopes RD, Moia DDF, Fonseca FA, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Guimaraes HP, de Barros E Silva PGM, Damiani LP, ... ... White HD, et al. Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial. Journal of the American College of Cardiology. PMID 30898608 DOI: 10.1016/j.jacc.2019.03.011 |
0.302 |
|
| 2019 |
Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Alexander KP, Senior R, Boden WE, Stone GW, Goodman SG, Lopes RD, Lopez-Sendon J, White HD, Maggioni AP, Shaw LJ, Min JK, et al. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. Jama Cardiology. PMID 30810700 DOI: 10.1001/jamacardio.2019.0014 |
0.313 |
|
| 2019 |
White HD. Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective. European Heart Journal. 40: e4-e7. PMID 21990262 DOI: 10.1093/eurheartj/ehq317 |
0.358 |
|
| 2019 |
Straznicky IT, French JK, White HD, Califf RM. Fibrinolysis for Acute Myocardial Infarction in the Elderly Patient: Is it Effective or Too Dangerous? The American Journal of Geriatric Cardiology. 7: 22-27. PMID 11416441 |
0.3 |
|
| 2019 |
Jukema JW, Szarek M, Roe M, Bhatt DL, Bittner V, Silva HAd, Diaz R, Goodman S, Hanotin C, Edelberg J, Harrington R, Karpov Y, Moryusef A, Pordy R, Prieto J, ... White H, et al. Post-Acute Coronary Syndrome Patients With Polyvascular Disease Derive Large Absolute Benefit From Alirocumab: Odyssey Outcomes Journal of the American College of Cardiology. 73: 2034. DOI: 10.1016/S0735-1097(19)32640-3 |
0.327 |
|
| 2019 |
Marquis-Gravel G, Neely M, Valgimigli M, Costa F, Van Klaveren D, Bhatt DL, Altner R, Armstrong P, Fox K, White H, Ohman EM, Roe M. COMPARISON OF BLEEDING RISK PREDICTION MODELS WITH DUAL ANTI-PLATELET THERAPY TREATMENT AMONG PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED MEDICALLY WITHOUT REVASCULARIZATION Journal of the American College of Cardiology. 73: 66. DOI: 10.1016/S0735-1097(19)30675-8 |
0.303 |
|
| 2019 |
Goodman SG, Aylward P, Szarek M, Chumburidze V, Bhatt DL, Bittner V, Diaz R, Edelberg J, Hanotin C, Harrington RA, Jukema JW, Kedev S, Moryusef A, Pordy R, López GAR, ... ... White HD, et al. Patients With Acute Coronary Syndrome, Elevated Atherogenic Lipoproteins, And Prior Coronary Artery Bypass Grafting Derive Large Absolute Benefit From Alirocumab: Insights From The Odyssey Outcomes Trial Journal of the American College of Cardiology. 73: 30. DOI: 10.1016/S0735-1097(19)30639-4 |
0.371 |
|
| 2018 |
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 138: e618-e651. PMID 30571511 DOI: 10.1161/CIR.0000000000000617 |
0.305 |
|
| 2018 |
Abtan J, Ducrocq G, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm C, Price MJ, Prats J, Elkin S, Deliargyris EN, White HD, Menozzi A, Harrington RA, Bhatt DL, et al. Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial. International Journal of Cardiology. PMID 30563770 DOI: 10.1016/j.ijcard.2018.11.114 |
0.321 |
|
| 2018 |
Fanaroff AC, Cyr D, Neely ML, Bakal J, White HD, Fox KAA, Armstrong PW, Lopes RD, Ohman EM, Roe MT. Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes. Circulation. Cardiovascular Quality and Outcomes. 11: e004755. PMID 30562068 DOI: 10.1161/CIRCOUTCOMES.118.004755 |
0.322 |
|
| 2018 |
Lambrakis K, French JK, Scott IA, Briffa T, Brieger D, Farkouh ME, White H, Chuang AM, Tiver K, Quinn S, Kaambwa B, Horsfall M, Morton E, Chew DP. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design. American Heart Journal. 208: 11-20. PMID 30522086 DOI: 10.1016/j.ahj.2018.09.016 |
0.404 |
|
| 2018 |
Szarek M, White HD, Schwartz GG, Alings M, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Kimura T, Kiss RG, et al. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial. Journal of the American College of Cardiology. PMID 30428396 DOI: 10.1016/j.jacc.2018.10.039 |
0.323 |
|
| 2018 |
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, ... ... White HD, et al. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. The New England Journal of Medicine. PMID 30403574 DOI: 10.1056/NEJMoa1801174 |
0.372 |
|
| 2018 |
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, et al. [Fourth universal definition of myocardial infarction (2018)]. Kardiologia Polska. 76: 1383-1415. PMID 30338834 DOI: 10.5603/Kp.2018.0203 |
0.305 |
|
| 2018 |
Stone GW, Généreux P, Harrington RA, White HD, Gibson CM, Steg PG, Hamm CW, Mahaffey KW, Price MJ, Prats J, Deliargyris EN, Bhatt DL. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial. European Heart Journal. PMID 30203006 DOI: 10.1093/eurheartj/ehy562 |
0.345 |
|
| 2018 |
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth universal definition of myocardial infarction (2018). European Heart Journal. PMID 30165617 DOI: 10.1093/eurheartj/ehy462 |
0.305 |
|
| 2018 |
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth Universal Definition of Myocardial Infarction (2018). Global Heart. PMID 30154043 DOI: 10.1016/j.gheart.2018.08.004 |
0.305 |
|
| 2018 |
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology. PMID 30153967 DOI: 10.1016/j.jacc.2018.08.1038 |
0.305 |
|
| 2018 |
Hinohara TT, Roe MT, White HD, Fox KAA, Bhatt DL, Hamm C, Gurbel PA, Aylward PE, Wiviott SD, Huber K, Neely ML, Ohman EM. Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial). The American Journal of Cardiology. PMID 30135019 DOI: 10.1016/j.amjcard.2018.06.052 |
0.385 |
|
| 2018 |
Olivier CB, Sundaram V, Bhatt DL, Leonardi S, Lopes RD, Ding VY, Yang L, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, White HD, Desai M, Lynch DR, et al. Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials. International Journal of Cardiology. PMID 29937301 DOI: 10.1016/j.ijcard.2018.06.034 |
0.384 |
|
| 2018 |
Berwanger O, Nicolau JC, Carvalho AC, Jiang L, Goodman S, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Kerr Saraiva JF, Fonseca F, Guimaraes HP, de Barros E Silva PGM, Damiani LP, ... ... White H, et al. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial. American Heart Journal. 202: 89-96. PMID 29908420 DOI: 10.1016/j.ahj.2018.02.017 |
0.353 |
|
| 2018 |
Tricoci P, Newby LK, Clare RM, Leonardi S, Gibson CM, Giugliano RP, Armstrong PW, Van de Werf F, Montalescot G, Moliterno DJ, Held C, Aylward PE, Wallentin L, Harrington RA, Braunwald E, ... ... White HD, et al. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention. Jacc. Cardiovascular Interventions. 11: 856-864. PMID 29747915 DOI: 10.1016/J.Jcin.2018.02.006 |
0.405 |
|
| 2018 |
Beltrame JF, Pasupathy S, Tavella R, White HD. How Can You Have a Myocardial Infarction Without Significant Coronary Artery Disease? Heart, Lung & Circulation. 27: 649-651. PMID 29706179 DOI: 10.1016/j.hlc.2018.03.006 |
0.343 |
|
| 2018 |
Yan AT, Roe MT, Neely M, Cyr DD, White H, Fox KAA, Prabhakaran D, Armstrong PW, Ohman EM, Goodman SG. Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial. Coronary Artery Disease. PMID 29652672 DOI: 10.1097/MCA.0000000000000623 |
0.358 |
|
| 2018 |
Groves EM, Bhatt DL, Steg PG, Deliargyris EN, Stone GW, Gibson CM, Hamm CW, Mahaffey KW, White HD, Angiolillo D, Prats J, Harrington RA, Price MJ. Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition). Circulation. Cardiovascular Interventions. 11: e005635. PMID 29632238 DOI: 10.1161/CIRCINTERVENTIONS.117.005635 |
0.331 |
|
| 2018 |
Berwanger O, Nicolau JC, Carvalho AC, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Fonseca FA, De Luca FA, Guimaraes HP, ... ... White HD, et al. Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial. Jama Cardiology. PMID 29525822 DOI: 10.1001/jamacardio.2018.0612 |
0.352 |
|
| 2018 |
Guimarães PO, Leonardi S, Huang Z, Wallentin L, de Werf FV, Aylward PE, Held C, Harrington RA, Moliterno DJ, Armstrong PW, White HD, Alexander KP, Lopes RD, Mahaffey KW, Tricoci P. Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. American Heart Journal. 196: 28-35. PMID 29421012 DOI: 10.1016/j.ahj.2017.10.007 |
0.396 |
|
| 2018 |
White H, Steg P, Szarek M, Bhatt D, Bittner V, Diaz R, Edelberg J, Goodman S, Hantoin C, Harrington R, Jukema J, Lecorps G, Moryusef A, Pordy R, Roe M, et al. Cardiovascular Outcomes With Alirocumab After Acute Coronary Syndrome: Results of the Odyssey Outcomes Trial Heart Lung and Circulation. 27. DOI: 10.1016/J.Hlc.2018.06.585 |
0.307 |
|
| 2017 |
Ellis CJ, Gamble GD, Williams MJA, Matsis P, Elliott JM, Devlin G, Mann S, French JK, White HD. All-Cause Mortality Following an Acute Coronary Syndrome: 12-Year Follow-Up of the Comprehensive 2002 New Zealand Acute Coronary Syndrome Audit. Heart, Lung & Circulation. PMID 29150157 DOI: 10.1016/j.hlc.2017.10.015 |
0.324 |
|
| 2017 |
Eisen A, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL. Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials. International Journal of Cardiology. PMID 29030140 DOI: 10.1016/j.ijcard.2017.10.006 |
0.412 |
|
| 2017 |
Vaduganathan M, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. PMID 28988157 DOI: 10.4244/EIJ-D-17-00723 |
0.316 |
|
| 2017 |
Vaduganathan M, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX). The American Journal of Cardiology. PMID 28802512 DOI: 10.1016/j.amjcard.2017.06.042 |
0.341 |
|
| 2017 |
Cavender MA, Bhatt DL, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Prats J, Elkin S, Deliargyris EN, Mahaffey KW, White HD, Harrington RA. Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIX. Circulation. Cardiovascular Interventions. 10. PMID 28801539 DOI: 10.1161/CIRCINTERVENTIONS.117.005257 |
0.304 |
|
| 2017 |
Dalby AJ, Gottlieb S, Cyr DD, Magnus Ohman E, McGuire DK, Ruzyllo W, Bhatt DL, Wiviott SD, Winters KJ, Fox KAA, Armstrong PW, White HD, Prabhakaran D, Roe MT. Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization. American Heart Journal. 188: 156-166. PMID 28577671 DOI: 10.1016/j.ahj.2017.03.015 |
0.341 |
|
| 2017 |
Hess CN, Clare RM, Neely ML, Tricoci P, Mahaffey KW, James SK, Alexander JH, Held C, Lopes RD, Fox KAA, White HD, Wallentin L, Armstrong PW, Harrington RA, Ohman EM, et al. Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome. American Heart Journal. 187: 194-203. PMID 28454804 DOI: 10.1016/j.ahj.2017.01.016 |
0.385 |
|
| 2017 |
Goldstein SA, Newby LK, Cyr DD, Neely M, Lüscher TF, Brown EB, White HD, Ohman EM, Roe MT, Hamm CW. Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes. Journal of the American Heart Association. 6. PMID 28400368 DOI: 10.1161/JAHA.116.005334 |
0.302 |
|
| 2017 |
Elliott JM, Wang TK, Gamble GD, Williams MJ, Matsis P, Troughton R, Hamer A, Devlin G, Mann S, Richards M, French JK, White HD, Ellis CJ. A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012. The New Zealand Medical Journal. 130: 17-28. PMID 28384143 |
0.345 |
|
| 2017 |
Alfredsson J, Neely B, Neely ML, Bhatt DL, Goodman SG, Tricoci P, Mahaffey KW, Cornel JH, White HD, Fox KA, Prabhakaran D, Winters KJ, Armstrong PW, Ohman EM, Roe MT, et al. Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes. Heart (British Cardiac Society). PMID 28381584 DOI: 10.1136/heartjnl-2016-310090 |
0.328 |
|
| 2017 |
Valgimigli M, Costa F, Lokhnygina Y, Clare RM, Wallentin L, Moliterno DJ, Armstrong PW, White HD, Held C, Aylward PE, Van de Werf F, Harrington RA, Mahaffey KW, Tricoci P. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. European Heart Journal. 38: 804-810. PMID 28363222 DOI: 10.1093/Eurheartj/Ehw525 |
0.41 |
|
| 2017 |
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 69: 176-185. PMID 28081827 DOI: 10.1016/j.jacc.2016.10.055 |
0.314 |
|
| 2017 |
Eisen A, Bonaca MP, Jarolim P, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry. 63: 307-315. PMID 28062625 DOI: 10.1373/Clinchem.2016.264788 |
0.377 |
|
| 2017 |
Sawlani NN, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL. Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention. Circulation. Cardiovascular Interventions. 10. PMID 28039321 DOI: 10.1161/CIRCINTERVENTIONS.116.004380 |
0.318 |
|
| 2017 |
Wang TKM, Liao Y, Wang MTM, Stewart R, White H. BLEEDING RISK MODELS IN ACUTE CORONARY SYNDROME: META-ANALYSIS OF PERFORMANCE Journal of the American College of Cardiology. 69: 224. DOI: 10.1016/S0735-1097(17)33613-6 |
0.303 |
|
| 2017 |
Goodman SG, Schwartz G, Bhatt DL, Bittner V, Diaz R, Hanotin C, Harrington R, Jukema J, Moryusef A, Pordy R, Roe M, Sasiela WJ, Szarek M, Tamby J, White H, et al. Use Of High-Intensity Statin Therapy Post-Acute Coronary Syndrome In The Ongoing Odyssey Outcomes Trial Of Alirocumab, A Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibody, Versus Placebo: Interim Baseline Data Journal of the American College of Cardiology. 69: 153. DOI: 10.1016/S0735-1097(17)33542-8 |
0.321 |
|
| 2017 |
Vaduganathan M, Harrington R, Stone G, Steg P, Gibson CM, Hamm C, Price M, Deliargyris E, Prats J, Mahaffey K, White H, Bhatt D. IMPACT OF PERIPROCEDURAL MYOCARDIAL INFARCTION IN CONTEMPORARY PCI: POOLED PATIENT-LEVEL DATA FROM THE CHAMPION TRIALS Journal of the American College of Cardiology. 69: 112. DOI: 10.1016/S0735-1097(17)33501-5 |
0.346 |
|
| 2017 |
Olivier C, Sundaram V, Ding V, Yang L, Leonardi S, Lopes R, Bhatt D, Stone G, Steg P, Gibson CM, Hamm C, Price M, White H, Desai M, Harrington R, et al. ONE-YEAR MORTALITY INCREASED IN PATIENTS WITH PERI-PROCEDURAL MYOCARDIAL INFARCTION: INSIGHTS FROM THE CHAMPION TRIALS Journal of the American College of Cardiology. 69: 7. DOI: 10.1016/S0735-1097(17)33396-X |
0.31 |
|
| 2017 |
Wang T, Liao Y, Wang M, Stewart R, White H. Prognostic Utility of Bleeding Risk Scores in Acute Coronary Syndrome: A Meta-Analysis Heart, Lung and Circulation. 26: S91. DOI: 10.1016/J.HLC.2017.06.111 |
0.313 |
|
| 2016 |
Cornel JH, Ohman EM, Neely B, Jakubowski JA, Bhatt DL, White HD, Ardissino D, Fox KA, Prabhakaran D, Armstrong PW, Erlinge D, Tantry US, Gurbel PA, Roe MT. Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. Journal of the American Heart Association. 5. PMID 27815268 DOI: 10.1161/JAHA.116.003977 |
0.371 |
|
| 2016 |
Abtan J, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm CW, Price MJ, Abnousi F, Prats J, Deliargyris EN, White HD, Harrington RA, Bhatt DL. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial. Jacc. Cardiovascular Interventions. 9: 1905-13. PMID 27659566 DOI: 10.1016/j.jcin.2016.06.046 |
0.348 |
|
| 2016 |
Adamo M, Ariotti S, Costa F, Curello S, Moschovitis A, de Vries T, White HD, Windecker S, Valgimigli M. Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial. Jacc. Cardiovascular Interventions. 9: 1667-76. PMID 27539685 DOI: 10.1016/j.jcin.2016.05.031 |
0.303 |
|
| 2016 |
Kerr A, Williams MJ, White H, Doughty R, Nunn C, Devlin G, Grey C, Lee M, Flynn C, Rhodes M, Sutherland K, Wells S, Jackson R, Stewart R. The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9). The New Zealand Medical Journal. 129: 23-36. PMID 27507719 |
0.317 |
|
| 2016 |
Armaganijan LV, Alexander KP, Huang Z, Tricoci P, Held C, Van de Werf F, Armstrong PW, Aylward PE, White HD, Moliterno DJ, Wallentin L, Chen E, Harrington RA, Strony J, Mahaffey KW, et al. Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. American Heart Journal. 178: 176-84. PMID 27502866 DOI: 10.1016/j.ahj.2016.05.012 |
0.355 |
|
| 2016 |
Kaul P, Ohman EM, Knight JD, Anstrom KJ, Roe MT, Boden WE, Hochman JS, Gašparović V, Armstrong PW, McCollam P, Fakhouri W, Cowper P, Davidson-Ray L, Clapp-Channing N, White HD, et al. Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial. American Heart Journal. 178: 55-64. PMID 27502852 DOI: 10.1016/J.Ahj.2016.03.017 |
0.351 |
|
| 2016 |
Åkerblom A, Clare RM, Lokhnygina Y, Wallentin L, Held C, Van de Werf F, Moliterno DJ, Patel UD, Leonardi S, Armstrong PW, Harrington RA, White HD, Aylward PE, Mahaffey KW, Tricoci P. Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial. American Heart Journal. 178: 1-8. PMID 27502846 DOI: 10.1016/J.Ahj.2016.04.013 |
0.379 |
|
| 2016 |
Leonardi S, Lopes RD, Steg PG, Abnousi F, Menozzi A, Prats J, Mangum S, Wilson M, Todd M, Stone GW, Gibson CM, Hamm CW, Price MJ, White HD, Harrington RA, et al. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience. European Heart Journal. Acute Cardiovascular Care. PMID 27485140 DOI: 10.1177/2048872616661692 |
0.366 |
|
| 2016 |
Cavender MA, Bhatt DL, Stone GW, White HD, Steg PG, Gibson CM, Hamm CW, Price MJ, Leonardi S, Prats J, Deliargyris EN, Mahaffey KW, Harrington RA. Consistent Reduction in Peri-Procedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX. Circulation. PMID 27482008 DOI: 10.1161/CIRCULATIONAHA.115.020829 |
0.344 |
|
| 2016 |
Jackson LR, Piccini JP, Cyr DD, Roe MT, Neely ML, Martinez F, Lüscher TF, Lopes RD, Winters KJ, White HD, Armstrong PW, Fox KA, Prabhakaran D, Bhatt DL, Magnus Ohman E, et al. Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial. Clinical Cardiology. PMID 27468086 DOI: 10.1002/clc.22562 |
0.304 |
|
| 2016 |
Hess PL, Wojdyla DM, Al-Khatib SM, Lokhnygina Y, Wallentin L, Armstrong PW, Roe MT, Ohman EM, Harrington RA, Alexander JH, White HD, Van de Werf F, Piccini JP, Held C, Aylward PE, et al. Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome. Jama Cardiology. 1: 73-9. PMID 27437658 DOI: 10.1001/Jamacardio.2015.0359 |
0.344 |
|
| 2016 |
Chin CT, Boden WE, Roe MT, Neely B, Neely ML, Leiva-Pons JL, Corbalán R, Gottlieb S, Dalby AJ, Armstrong PW, Prabhakaran D, Fox KA, White HD, Ohman EM, Winters KJ, et al. Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients. Heart (British Cardiac Society). PMID 27030601 DOI: 10.1136/heartjnl-2015-308840 |
0.331 |
|
| 2016 |
Lopes RD, Leonardi S, Neely B, Neely ML, Ohman EM, Ardissino D, Hamm CW, Goodman SG, Bhatt DL, White HD, Prabhakaran D, Martinez F, Nicolau JC, Winters KJ, Fox KA, et al. Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial. Journal of the American College of Cardiology. 67: 1289-97. PMID 26988949 DOI: 10.1016/j.jacc.2016.01.034 |
0.356 |
|
| 2016 |
Devlin G, Williams M, Elliott J, White HD, French J, Gamble G, Matsis P, Troughton R, Richards M, Ellis C. Management of non ST-elevationacute coronary syndrome patients in New Zealand: a longitudinal analysis. Results from the New Zealand Acute Coronary Syndrome national audits of 2002, 2007 and 2012. The New Zealand Medical Journal. 129: 10-6. PMID 26914189 |
0.324 |
|
| 2016 |
Costa F, Valgimigli M, Lokhnygina Y, Clare R, Wallentin L, Moliterno D, Armstrong P, White H, Held C, Aylward P, Werf FVd, Harrington R, Mahaffey K, Tricoci P. Tradeoff Between Myocardial Infarction Versus Bleeding Types On Mortality After Acute Coronary Syndrome: Lessons From The Thrombin Receptor Antagonist For Clinical Event Reduction In Acute Coronary Syndrome (Tracer) Randomized Trial Journal of the American College of Cardiology. 67: 456-456. DOI: 10.1016/S0735-1097(16)30457-0 |
0.381 |
|
| 2015 |
Déry JP, Mahaffey KW, Tricoci P, White HD, Podder M, Westerhout CM, Moliterno DJ, Harrington RA, Chen E, Strony J, Van de Werf F, Ziada KM, Held C, Aylward PE, Armstrong PW, et al. Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 26698636 DOI: 10.1002/ccd.26335 |
0.344 |
|
| 2015 |
van Diepen S, Tricoci P, Podder M, Westerhout CM, Aylward PE, Held C, Van de Werf F, Strony J, Wallentin L, Moliterno DJ, White HD, Mahaffey KW, Harrington RA, Armstrong PW. Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery. Journal of the American Heart Association. 4. PMID 26672080 DOI: 10.1161/JAHA.115.002546 |
0.334 |
|
| 2015 |
Roe MT, Cyr DD, Eckart D, Schulte PJ, Morse MA, Blackwell KL, Ready NE, Zafar SY, Beaven AW, Strickler JH, Onken JE, Winters KJ, Houterloot L, Zamoryakhin D, Wiviott SD, ... White HD, et al. Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. European Heart Journal. PMID 26637834 DOI: 10.1093/Eurheartj/Ehv611 |
0.325 |
|
| 2015 |
Halim SA, Clare RM, Newby LK, Lokhnygina Y, Schweiger MJ, Hof AW, Hochman JS, James SK, White HD, Widimsky P, Betriu A, Bode C, Giugliano RP, Harrington RA, Zeymer U. Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions. International Journal of Cardiology. 203: 708-713. PMID 26587725 DOI: 10.1016/J.Ijcard.2015.11.036 |
0.341 |
|
| 2015 |
Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FW, Armstrong PW, White HD, Fox KA, Prabhakaran D, et al. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial. American Heart Journal. 170: 683-694.e3. PMID 26386792 DOI: 10.1016/J.Ahj.2015.05.017 |
0.348 |
|
| 2015 |
Mahaffey KW, Hager R, Wojdyla D, White HD, Armstrong PW, Alexander JH, Tricoci P, Lopes RD, Ohman EM, Roe MT, Harrington RA, Wallentin L. Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes. Journal of the American Heart Association. 4: e001512. PMID 26089177 DOI: 10.1161/JAHA.114.001512 |
0.348 |
|
| 2015 |
Bagai A, Huang Z, Lokhnygina Y, Harrington RA, Armstrong PW, Strony J, White HD, Leonardi S, Held C, Van de Werf F, Wallentin L, Tricoci P, Mahaffey KW. Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization. Circulation. Cardiovascular Interventions. 8: e002314. PMID 26025218 DOI: 10.1161/Circinterventions.115.002314 |
0.371 |
|
| 2015 |
White HD, Westerhout CM, Alexander KP, Roe MT, Winters KJ, Cyr DD, Fox KA, Prabhakaran D, Hochman JS, Armstrong PW, Ohman EM. Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. European Heart Journal. Acute Cardiovascular Care. PMID 25897147 DOI: 10.1177/2048872615581502 |
0.353 |
|
| 2015 |
Ellis C, Hammett C, Ranasinghe I, French J, Briffa T, Devlin G, Elliott J, Lefkovitz J, Aliprandi-Costa B, Astley C, Redfern J, Howell T, Carr B, Lintern K, Bloomer S, ... ... White H, et al. Comparison of the management and in-hospital outcomes of acute coronary syndrome patients in Australia and New Zealand: results from the binational SNAPSHOT acute coronary syndrome 2012 audit. Internal Medicine Journal. 45: 497-509. PMID 25764311 DOI: 10.1111/imj.12739 |
0.345 |
|
| 2015 |
White HD, Bhatt DL, Gibson CM, Hamm CW, Mahaffey KW, Price MJ, Steg PG, Stone GW, Cortese B, Wilensky M, Deliargyris EN, Liu T, Prats J, Harrington RA. Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]). Jacc. Cardiovascular Interventions. 8: 424-33. PMID 25703887 DOI: 10.1016/j.jcin.2014.09.025 |
0.303 |
|
| 2015 |
Warren J, Mehran R, Yu J, Xu K, Bertrand ME, Cox DA, Lincoff AM, Manoukian SV, Ohman EM, Pocock SJ, White HD, Stone GW. Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction. The American Journal of Cardiology. 115: 428-33. PMID 25542393 DOI: 10.1016/j.amjcard.2014.11.023 |
0.346 |
|
| 2015 |
Roy A, Roe MT, Neely ML, Cyr DD, Zamoryakhin D, Fox KA, White HD, Armstrong PW, Ohman EM, Prabhakaran D. Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome. Heart (British Cardiac Society). 101: 279-86. PMID 25538134 DOI: 10.1136/heartjnl-2014-306389 |
0.308 |
|
| 2015 |
Vedin O, Hagstrom E, Budaj A, Denchev S, Harrington R, Koenig W, Soffer J, Sritara P, Stebbins A, Stewart R, Swart H, Viigimaa M, Vinereanu D, Wallentin L, White H, et al. TOOTH LOSS IS INDEPENDENTLY ASSOCIATED WITH ADVERSE OUTCOME BUT NOT MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC CORONARY HEART DISEASE Journal of the American College of Cardiology. 65: A1421. DOI: 10.1016/S0735-1097(15)61421-8 |
0.356 |
|
| 2015 |
Magnani G, O’Donoghue M, Braunwald E, Steen D, Jarolim P, Lukas MA, White H, Lewis B, Winter Rd, Zhou J, Im K, Cannon C, Morrow D. Galectin-3 For Heart Failure Risk Stratification In Patients After Acute Coronary Syndromes (Acs): Insights From The Solid-Timi 52 Trial Journal of the American College of Cardiology. 65. DOI: 10.1016/S0735-1097(15)60773-2 |
0.327 |
|
| 2015 |
Clemmensen P, Roe MT, Hochman JS, Cyr DD, Neely ML, McGuire DK, Cornel JH, Huber K, Zamoryakhin D, White HD, Armstrong PW, Fox KAA, Prabhakaran D, Ohman EM. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial American Heart Journal. DOI: 10.1016/j.ahj.2015.06.011 |
0.306 |
|
| 2014 |
Tricoci P, Lokhnygina Y, Huang Z, Van de Werf F, Cornel JH, Chen E, Wallentin L, Held C, Aylward PE, Moliterno DJ, Jennings LK, White HD, Armstrong PW, Harrington RA, Strony J, et al. Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. American Heart Journal. 168: 869-77.e1. PMID 25458650 DOI: 10.1016/J.Ahj.2014.09.002 |
0.341 |
|
| 2014 |
Jones WS, Tricoci P, Huang Z, Moliterno DJ, Harrington RA, Sinnaeve PR, Strony J, Van de Werf F, White HD, Held C, Armstrong PW, Aylward PE, Chen E, Patel MR, Mahaffey KW. Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER). American Heart Journal. 168: 588-96. PMID 25262270 DOI: 10.1016/j.ahj.2014.06.017 |
0.355 |
|
| 2014 |
Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, et al. Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). The American Journal of Cardiology. 114: 665-73. PMID 25129064 DOI: 10.1016/J.Amjcard.2014.05.054 |
0.365 |
|
| 2014 |
Planer D, Mehran R, Ohman EM, White HD, Newman JD, Xu K, Stone GW. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the acute catheterization and urgent intervention triage strategy trial. Circulation. Cardiovascular Interventions. 7: 285-93. PMID 24847016 DOI: 10.1161/CIRCINTERVENTIONS.113.000606 |
0.372 |
|
| 2014 |
Mueller M, Biener M, Vafaie M, Blankenberg S, White HD, Katus HA, Giannitsis E. Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome. International Journal of Cardiology. 174: 524-9. PMID 24814895 DOI: 10.1016/j.ijcard.2014.04.110 |
0.321 |
|
| 2014 |
Adlbrecht C, Huber K, Reynolds HR, Carvalho AC, DžavÃk V, Steg PG, Liu L, Marino P, Pearte CA, Rankin JM, White HD, Lamas GA, Hochman JS. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction. International Journal of Cardiology. 174: 90-5. PMID 24726166 DOI: 10.1016/j.ijcard.2014.03.149 |
0.306 |
|
| 2014 |
Lansky AJ, Ng VG, Meller S, Xu K, Fahy M, Feit F, Ohman EM, White HD, Mehran R, Bertrand ME, Desmet W, Hamon M, Stone GW. Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy). Jacc. Cardiovascular Interventions. 7: 266-75. PMID 24650400 DOI: 10.1016/j.jcin.2013.08.016 |
0.368 |
|
| 2014 |
Held C, Tricoci P, Huang Z, Van de Werf F, White HD, Armstrong PW, Ambrosio G, Aylward PE, Moliterno DJ, Wallentin L, Chen E, Erkan A, Jiang L, Strony J, Harrington RA, et al. Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial. European Heart Journal. Acute Cardiovascular Care. 3: 246-56. PMID 24627331 DOI: 10.1177/2048872614527838 |
0.321 |
|
| 2014 |
De Ferrari GM, Fox KA, White JA, Giugliano RP, Tricoci P, Reynolds HR, Hochman JS, Gibson CM, Théroux P, Harrington RA, Van de Werf F, White HD, Califf RM, Newby LK. Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. European Heart Journal. Acute Cardiovascular Care. 3: 37-45. PMID 24562802 DOI: 10.1177/2048872613489315 |
0.353 |
|
| 2014 |
Alpert JS, Thygesen KA, White HD, Jaffe AS. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. The American Journal of Medicine. 127: 105-8. PMID 24462011 DOI: 10.1016/j.amjmed.2013.09.031 |
0.302 |
|
| 2014 |
Meier P, Lansky AJ, Fahy M, Xu K, White HD, Bertrand ME, Mehran R, Stone GW. The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial. Heart (British Cardiac Society). 100: 647-51. PMID 24310521 DOI: 10.1136/heartjnl-2013-304435 |
0.358 |
|
| 2014 |
Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, Marhefka GD, Held C, Nicolau JC, Storey RF, Ruzyllo W, Huber K, Sinnaeve P, Weiss AT, Dery JP, ... ... White HD, et al. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). Journal of the American College of Cardiology. 63: 1048-57. PMID 24211500 DOI: 10.1016/j.jacc.2013.10.048 |
0.346 |
|
| 2014 |
Chin CT, Boden W, Roe M, Neely B, Neely M, Leiva-Pons J, Ramon C, Bassand J, Gottlieb S, Dalby A, Armstrong P, Prabhakaran D, Fox K, White H, Ohman EM, et al. IMPACT OF PRIOR CLOPIDOGREL USE ON ISCHEMIC OUTCOMES AMONG MEDICALLY MANAGED PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES: RESULTS FROM THE TRILOGY ACS TRIAL Journal of the American College of Cardiology. 63: A104. DOI: 10.1016/S0735-1097(14)60104-2 |
0.357 |
|
| 2014 |
Piccini JP, Cyr D, Roe M, Neely M, Martinez F, Luscher T, Lopes R, Winters K, White H, Armstrong P, Fox K, Prabhakaran D, Bhatt D, Ohman EM, Corbalan R. DUAL ANTIPLATELET THERAPY AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROMES Journal of the American College of Cardiology. 63: A103. DOI: 10.1016/S0735-1097(14)60103-0 |
0.339 |
|
| 2014 |
White HD, Bhatt DL, Gibson CM, Hamm CW, Mahaffey KW, Price MJ, Steg PG, Stone GW, Cortese B, Wilensky M, Deliargyris EN, Liu T, Prats J, Harrington RA. REDUCED DEATH, MYOCARDIAL INFARCTION, AND EARLY STENT THROMBOSIS WITH CANGRELOR VERSUS CLOPIDOGREL ON A BACKGROUND OF BIVALIRUDIN: INSIGHTS FROM CHAMPION PHOENIX Journal of the American College of Cardiology. 63: A36. DOI: 10.1016/S0735-1097(14)60036-X |
0.315 |
|
| 2014 |
Elliott J, Williams M, Matsis P, Gamble G, Troughton R, Hamer A, Devlin G, Mann S, Richards A, French J, White H, Ellis C. A decade of improvement in investigations received and treatments delivered to New Zealand (NZ) ST-elevation myocardial infarction (STEMI) patients: Results from the NZACS national audits of 2002, 2007 and 2012 Heart, Lung and Circulation. 23: e22-e23. DOI: 10.1016/J.HLC.2014.04.185 |
0.327 |
|
| 2014 |
Devlin G, Hamer A, Throughton R, Gamble G, Matsis P, Williams M, Elliott J, Mann S, Richards A, French J, White H, Ellis C. Management of non ST-elevation acute coronary syndrome (NSTEACS) patients in New Zealand (NZ): A longitudinal analysis. Results from the NZACS national audits of 2002, 2007 and 2012 Heart, Lung and Circulation. 23: e8-e9. DOI: 10.1016/J.HLC.2014.04.148 |
0.342 |
|
| 2014 |
Ming Wang TK, Snow T, Watson T, Ruygrok P, White H. PM461 Higher Pre-Catheterisation High-Sensitivity Troponin Levels In Maori And Pacific Patients With St-Elevation Myocardial Infarction In New Zealand: Implications For Reducing Ethnic Disparities In Cardiovascular Outcomes Global Heart. 9: e156. DOI: 10.1016/J.GHEART.2014.03.1782 |
0.313 |
|
| 2014 |
Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FWA, Armstrong PW, White HD, Fox KAA, Prabhakaran D, et al. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial American Heart Journal. DOI: 10.1016/j.ahj.2015.05.017 |
0.315 |
|
| 2013 |
Bahit MC, Lopes RD, Clare RM, Newby LK, Pieper KS, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Diaz R, Ohman EM, White HD, James S, Granger CB. Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes. Jacc. Heart Failure. 1: 223-9. PMID 24621874 DOI: 10.1016/j.jchf.2013.02.007 |
0.314 |
|
| 2013 |
Weisz G, Farzaneh-Far R, Ben-Yehuda O, Debruyne B, Montalescot G, Lerman A, Mahmud E, Alexander KP, Ohman EM, White HD, Olmsted A, Walker GA, Stone GW. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial. American Heart Journal. 166: 953-959.e3. PMID 24268208 DOI: 10.1016/j.ahj.2013.08.004 |
0.314 |
|
| 2013 |
Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, ... White HD, et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet. 382: 1981-92. PMID 24011551 DOI: 10.1016/S0140-6736(13)61615-3 |
0.359 |
|
| 2013 |
Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, et al. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet (London, England). 382: 605-13. PMID 23953385 DOI: 10.1016/S0140-6736(13)61451-8 |
0.391 |
|
| 2013 |
Alherbish A, Westerhout CM, Fu Y, White HD, Granger CB, Wagner G, Armstrong PW. The forgotten lead: does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients? American Heart Journal. 166: 333-9. PMID 23895817 DOI: 10.1016/j.ahj.2013.05.018 |
0.321 |
|
| 2013 |
Tricoci P, Leonardi S, White J, White HD, Armstrong PW, Montalescot G, Giugliano RP, Gibson CM, Van de Werf F, Califf RM, Harrington RA, Braunwald E, Mahaffey KW, Newby LK. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. Journal of the American College of Cardiology. 62: 242-51. PMID 23684676 DOI: 10.1016/J.Jacc.2013.04.043 |
0.386 |
|
| 2013 |
Lopes RD, White JA, Atar D, Keltai M, Kleiman NS, White HD, Widimsky P, Zeymer U, Giugliano RP, Tricoci P, Braunwald E, Bode C, Ohman EM, Armstrong PW, Newby LK. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. International Journal of Cardiology. 168: 2510-7. PMID 23578889 DOI: 10.1016/J.Ijcard.2013.03.037 |
0.346 |
|
| 2013 |
Wong CK, White HD. Rivaroxaban for the treatment of acute coronary syndromes. Expert Opinion On Pharmacotherapy. 14: 917-27. PMID 23544968 DOI: 10.1517/14656566.2013.780029 |
0.343 |
|
| 2013 |
Leonardi S, Tricoci P, White HD, Armstrong PW, Huang Z, Wallentin L, Aylward PE, Moliterno DJ, Van de Werf F, Chen E, Providencia L, Nordrehaug JE, Held C, Strony J, Rorick TL, et al. Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial. European Heart Journal. 34: 1723-31. PMID 23530022 DOI: 10.1093/eurheartj/eht104 |
0.394 |
|
| 2013 |
Rose JJ, Newby LK, Broderick S, Chiswell K, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, Giugliano RP, Goodman SG, White HD, Califf RM, Granger CB, Lopes RD. Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes. Journal of the American College of Cardiology. 61: 1461-3. PMID 23500249 DOI: 10.1016/j.jacc.2012.12.032 |
0.346 |
|
| 2013 |
Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Todd M, Bhatt DL, Stone GW, Lincoff AM, Dauerman HL, Gibson CM, White HD, Parikh KH, Gruberg L, Herrmann HC, McLaurin BT, et al. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial. Coronary Artery Disease. 24: 321-7. PMID 23442944 DOI: 10.1097/Mca.0B013E32835F2Fbd |
0.352 |
|
| 2013 |
Leonardi S, Truffa AA, Neely ML, Tricoci P, White HD, Gibson CM, Wilson M, Stone GW, Harrington RA, Bhatt DL, Mahaffey KW. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial. Heart (British Cardiac Society). 99: 1282-7. PMID 23434768 DOI: 10.1136/heartjnl-2012-303103 |
0.311 |
|
| 2013 |
Ezekowitz JA, Bakal JA, Westerhout CM, Giugliano RP, White H, Keltai M, Prabhakaran D, Tricoci P, Van de Werf F, Califf RM, Newby LK, Armstrong PW. The relationship between meteorological conditions and index acute coronary events in a global clinical trial. International Journal of Cardiology. 168: 2315-21. PMID 23416014 DOI: 10.1016/j.ijcard.2013.01.061 |
0.302 |
|
| 2013 |
Lopes RD, White JA, Tricoci P, White HD, Armstrong PW, Braunwald E, Giugliano RP, Harrington RA, Lewis BS, Brogan GX, Gibson CM, Califf RM, Newby LK. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. International Journal of Cardiology. 167: 2580-7. PMID 22795720 DOI: 10.1016/J.Ijcard.2012.06.053 |
0.358 |
|
| 2013 |
Chan MY, Sun JL, Newby LK, Lokhnygina Y, White HD, Moliterno DJ, Théroux P, Ohman EM, Simoons ML, Mahaffey KW, Pieper KS, Giugliano RP, Armstrong PW, Califf RM, Van de Werf F, et al. Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years. International Journal of Cardiology. 167: 548-54. PMID 22341697 DOI: 10.1016/J.Ijcard.2012.01.065 |
0.353 |
|
| 2013 |
Roy A, Roe M, Cyr D, Zamoryakhin D, Fox K, White H, Armstrong P, Ohman EM, Prabhakaran D. Differences in the profile and risk of acute coronary syndrome patients stratified by country-level human development index: results from the global TRILOGY ACS trial European Heart Journal. 34: P2505-P2505. DOI: 10.1093/EURHEARTJ/EHT308.P2505 |
0.321 |
|
| 2013 |
Cornel J, Ohman EM, Neely B, Clemmensen P, Sritara P, Zamoryakhin D, Armstrong P, Prabhakaran D, White H, Fox K, Gurbel P, Roe M. IMPACT OF SMOKING STATUS ON CLINICAL OUTCOMES WITH PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES MANAGED WITHOUT revascularization: INSIGHTS FROM THE TRILOGY ACS TRIAL Journal of the American College of Cardiology. 61: E159. DOI: 10.1016/S0735-1097(13)60160-6 |
0.319 |
|
| 2013 |
Cornel JH, Tricoci P, Horton j, Moliterno D, Wallentin L, Armstrong P, Aylward P, Huang Z, Lokhnygina Y, Chen E, Leonardi S, Werf FVd, White H, Held C, Strony J, et al. Effects Of Glycoprotein Iib/Iiia Inhibitors In Combination With Vorapaxar, A Platelet Thrombin-Receptor Antagonist, Among Patients With Non-St-Segment Elevation Acute Coronary Syndromes: Insights From The Tracer Trial Journal of the American College of Cardiology. 61. DOI: 10.1016/S0735-1097(13)60103-5 |
0.328 |
|
| 2013 |
Nicolau JC, Bhatt D, Roe M, Neely B, Corbalan R, Leiva-Pons J, Martinez F, Goodman S, Brown E, Verheugt F, Armstrong P, White H, Fox K, Prabhakaran D, Ohman EM. THE ASSOCIATION BETWEEN CONCOMITANT PROTON-PUMP INHIBITOR USE AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH PRASUGREL VERSUS CLOPIDOGREL AND MANAGED WITHOUT REVASCULARIZATION: INSIGHTS FROM THE TRILOGY ACS STUDY Journal of the American College of Cardiology. 61: E39. DOI: 10.1016/S0735-1097(13)60040-6 |
0.336 |
|
| 2013 |
Wang T, Stewart R, Ramanathan T, Kang N, Gamble G, White H. Utility of High-sensitivity Troponin T After Coronary Artery Bypass Grafting to Diagnose Peri-operative Myocardial Infarction and to Predict Mortality Heart, Lung and Circulation. 22: S240-S241. DOI: 10.1016/J.HLC.2013.05.572 |
0.307 |
|
| 2013 |
Ellis C, Gamble G, Hamer A, Matsis P, Williams M, Devlin G, Elliott J, Mann S, French J, Richards M, Troughton R, White H. Improving Interventional Management of Acute Coronary Syndrome (ACS) Patients in New Zealand (NZ): A Comparison of the 2002, 2007 and 2012 National ACS Audits Heart, Lung and Circulation. 22: S218. DOI: 10.1016/J.HLC.2013.05.519 |
0.306 |
|
| 2013 |
Wang T, Stewart R, Ramanathan T, Kang N, Gamble G, White H. Myocardial Infarction After Coronary Artery Bypass Grafting Diagnosed with High-Sensitivity Troponin T and Associations with Mortality Heart, Lung and Circulation. 22: 590. DOI: 10.1016/J.HLC.2013.04.099 |
0.316 |
|
| 2013 |
Ellis C, Gamble G, Devlin G, Elliott J, Matsis P, Williams M, Hamer A, Mann S, French J, Richards A, Troughton R, White H. Significant Delays to Access Cardiac Angiography for Acute Coronary Syndrome (ACS) Patients in New Zealand (NZ): A Comparison of the National 2002, 2007 and (Snapshot) 2012 ACS Audits Heart, Lung and Circulation. 22: 556. DOI: 10.1016/J.HLC.2013.04.022 |
0.335 |
|
| 2012 |
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Global Heart. 7: 275-95. PMID 25689940 DOI: 10.1016/j.gheart.2012.08.001 |
0.304 |
|
| 2012 |
Snow TA, McEntee JP, Greaves SC, White HD. Myocardial infarction following sclerotherapy in a patient with a patent foramen ovale. The New Zealand Medical Journal. 125: 64-7. PMID 23254527 |
0.37 |
|
| 2012 |
Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H, Henriques JP, Ohman EM, White HD, Stone GW. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. Jacc. Cardiovascular Interventions. 5: 1097-105. PMID 23174632 DOI: 10.1016/j.jcin.2012.07.012 |
0.338 |
|
| 2012 |
Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KW. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction. Journal of the American College of Cardiology. 60: 2296-304. PMID 23122801 DOI: 10.1016/j.jacc.2012.09.005 |
0.351 |
|
| 2012 |
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, et al. Third universal definition of myocardial infarction. Journal of the American College of Cardiology. 60: 1581-98. PMID 22958960 DOI: 10.1016/j.jacc.2012.08.001 |
0.304 |
|
| 2012 |
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, et al. Third universal definition of myocardial infarction. Circulation. 126: 2020-35. PMID 22923432 DOI: 10.1161/CIR.0b013e31826e1058 |
0.304 |
|
| 2012 |
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Nature Reviews. Cardiology. 9: 620-33. PMID 22922597 DOI: 10.1038/nrcardio.2012.122 |
0.304 |
|
| 2012 |
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, et al. Third universal definition of myocardial infarction. European Heart Journal. 33: 2551-67. PMID 22922414 DOI: 10.1093/eurheartj/ehs184 |
0.304 |
|
| 2012 |
Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. The New England Journal of Medicine. 367: 1297-309. PMID 22920930 DOI: 10.1056/Nejmoa1205512 |
0.391 |
|
| 2012 |
Latif M, Ellis C, Chataline A, Gamble G, Kyle C, White H. Availability of troponin testing for cardiac patients in New Zealand 2002 to 2011: implications for patient care. The New Zealand Medical Journal. 125: 44-61. PMID 22854360 |
0.34 |
|
| 2012 |
White HD, Reynolds HR, Carvalho AC, Pearte CA, Liu L, Martin CE, Knatterud GL, Džavík V, Kruk M, Steg PG, Cantor WJ, Menon V, Lamas GA, Hochman JS. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort. American Heart Journal. 163: 563-71. PMID 22520521 DOI: 10.1016/j.ahj.2012.01.016 |
0.392 |
|
| 2012 |
White HD, Chew DP, Dauerman HL, Mahaffey KW, Gibson CM, Stone GW, Gruberg L, Harrington RA, Bhatt DL. Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. American Heart Journal. 163: 182-90.e4. PMID 22305835 DOI: 10.1016/j.ahj.2011.11.001 |
0.391 |
|
| 2012 |
Skolnick AH, Reynolds HR, White HD, Menon V, Carvalho AC, Maggioni AP, Pearte CA, Gruberg L, Azevedo RE, Schroeder E, Forman SA, Lamas GA, Hochman JS, Džavík V. Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial). The American Journal of Cardiology. 109: 614-9. PMID 22172242 DOI: 10.1016/j.amjcard.2011.10.015 |
0.326 |
|
| 2012 |
Wong CK, Gao W, Stewart RA, French JK, Aylward PE, White HD. The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction. European Heart Journal. 33: 384-92. PMID 21856681 DOI: 10.1093/eurheartj/ehr301 |
0.328 |
|
| 2012 |
Wong CK, White HD. Electrocardiography in acute coronary syndromes Advances in Acute Coronary Syndrome Management. 111-122. DOI: 10.2217/EBO.11.326 |
0.32 |
|
| 2012 |
Leonardi S, Tricoci P, White H, Armstrong P, Huang Z, Wallentin L, Aylward P, Moliterno D, Van de Werf F, Chen E, Providencia L, Nordrehaug JE, Held C, Strony J, Rorick T, et al. REDUCTION OF MYOCARDIAL INFARCTION WITH VORAPAXAR: RESULTS FROM THE TRA·CER TRIAL Journal of the American College of Cardiology. 59: E508. DOI: 10.1016/S0735-1097(12)60509-9 |
0.314 |
|
| 2012 |
Planer D, Ohman EM, White H, Moses J, Fahy M, Mehran R, Stone G. TCT-472 Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY Trial Journal of the American College of Cardiology. 60. DOI: 10.1016/J.Jacc.2012.08.504 |
0.334 |
|
| 2012 |
Ellis C, Gamble G, Devlin G, Hamer A, Elliott J, Matsis P, Williams M, Mann S, French J, Richards A, White H. All Cause Mortality Following an Acute Coronary Syndrome (ACS) Admission: Six Year Follow-up of the 2002 New Zealand (NZ) Acute Coronary Syndromes Audit Heart, Lung and Circulation. 21: S241-S242. DOI: 10.1016/J.HLC.2012.05.594 |
0.328 |
|
| 2012 |
Lin A, Looi J, Looi K, Chow K, Roberts F, White H, Webster M, Ellis C. Primary Percutaneous Coronary Intervention for Patients with St Elevation Myocardial Infarction—Past and Present at Auckland City Hospital Heart, Lung and Circulation. 21: 496-497. DOI: 10.1016/J.HLC.2012.03.055 |
0.34 |
|
| 2012 |
Ellis C, Gamble G, Hamer A, Devlin G, Elliott J, Matsis P, Williams M, Mann S, French J, Richards A, White H. Is the Mortality Risk Following an Acute Coronary Syndrome (ACS) Admission to a Non-intervention Centre Related to Access to Cardiac Angiography? Eighteen Month Follow-up of the 2002/2007 New Zealand (NZ) ACS Audits Heart, Lung and Circulation. 21: 488. DOI: 10.1016/J.HLC.2012.03.034 |
0.331 |
|
| 2012 |
Goodman SG, Roe MT, Armstrong PW, White HD, Fox KA, Prabhakaran D, Brown E, Lokhnygina Y, Ohman E. 903 The Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) Trial Canadian Journal of Cardiology. 28. DOI: 10.1016/J.Cjca.2012.07.743 |
0.32 |
|
| 2011 |
Hochman JS, Reynolds HR, DzavÃk V, Buller CE, Ruzyllo W, Sadowski ZP, Maggioni AP, Carvalho AC, Rankin JM, White HD, Goldberg S, Forman SA, Mark DB, Lamas GA. Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction. Circulation. 124: 2320-8. PMID 22025606 DOI: 10.1161/CIRCULATIONAHA.111.041749 |
0.358 |
|
| 2011 |
O'Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. American Heart Journal. 162: 613-619.e1. PMID 21982651 DOI: 10.1016/J.Ahj.2011.07.018 |
0.372 |
|
| 2011 |
Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery. The New Zealand Medical Journal. 124: 18-27. PMID 21964009 |
0.339 |
|
| 2011 |
Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, ... ... White H, et al. Apixaban with antiplatelet therapy after acute coronary syndrome. The New England Journal of Medicine. 365: 699-708. PMID 21780946 DOI: 10.1056/Nejmoa1105819 |
0.33 |
|
| 2011 |
Goto K, Lansky AJ, Nikolsky E, Fahy M, Feit F, Ohman EM, White HD, Mehran R, Bertrand ME, Desmet W, Hamon M, Stone GW. Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. Jacc. Cardiovascular Interventions. 4: 769-77. PMID 21777885 DOI: 10.1016/j.jcin.2011.02.019 |
0.356 |
|
| 2011 |
Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, et al. Impact of bleeding on mortality after percutaneous coronary intervention: Results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trials Jacc: Cardiovascular Interventions. 4: 654-664. PMID 21700252 DOI: 10.1016/j.jcin.2011.02.011 |
0.372 |
|
| 2011 |
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, ... ... White H, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 123: 2736-47. PMID 21670242 DOI: 10.1161/Circulationaha.110.009449 |
0.362 |
|
| 2011 |
Lansky A, Goto K, Fahy M, Cristea E, Mehran R, Stone GW, Feit F, Ohman EM, Alexander KP, White HD, Bertrand ME, Desmet W, Hamon M. Response to letters regarding article, “Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudyâ€. Circulation. 123: e410-1. PMID 21648119 DOI: 10.1161/CIRCULATIONAHA.110.010306 |
0.332 |
|
| 2011 |
Hakim DA, Dangas GD, Caixeta A, Nikolsky E, Lansky AJ, Moses JW, Claessen B, Sanidas E, White HD, Ohman EM, Manoukian SV, Fahy M, Mehran R, Stone GW. Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. American Heart Journal. 161: 391-6. PMID 21315224 DOI: 10.1016/j.ahj.2010.11.001 |
0.353 |
|
| 2011 |
Caixeta A, Dangas GD, Mehran R, Feit F, Nikolsky E, Lansky AJ, Aoki J, Moses JW, Steinhubl SR, White HD, Ohman EM, Manoukian SV, Fahy M, Stone GW. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. American Heart Journal. 161: 298-306.e1. PMID 21315212 DOI: 10.1016/j.ahj.2010.10.035 |
0.355 |
|
| 2011 |
Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ. The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circulation. Cardiovascular Quality and Outcomes. 4: 211-9. PMID 21304094 DOI: 10.1161/Circoutcomes.109.853598 |
0.303 |
|
| 2011 |
Mehta RH, O'Shea JC, Stebbins AL, Granger CB, Armstrong PW, White HD, Topol EJ, Califf RM, Ohman EM. Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis. Journal of the American College of Cardiology. 57: 138-46. PMID 21211684 DOI: 10.1016/j.jacc.2010.09.021 |
0.313 |
|
| 2011 |
Ambrosio G, Steinhubl S, Gresele P, Tritto I, Zuchi C, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Mehran R, Stone GW. Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial. European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 18: 121-8. PMID 20523219 DOI: 10.1097/HJR.0b013e32833bc070 |
0.338 |
|
| 2011 |
Steg PG, Kerner A, Mancini GBJ, Buller CE, Carvalho AC, Forman SA, Fridrich V, Reynolds HR, Hochman JS, Lamas GA, White HD. Reply to letter regarding article, the impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: A report from the randomized occluded artery trial Circulation. 123: e257-e258. DOI: 10.1161/CIRCULATIONAHA.110.008805 |
0.324 |
|
| 2011 |
Leonardi S, Thomas L, Koehler ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Newby LK. WHAT THRESHOLD SHOULD BE USED TO DEFINE PERCUTANEOUS CORONARY INTERVENTION-RELATED MYOCARDIAL INFARCTION? AN APPROACH BASED ON CLINICAL RELEVANCE FROM EARLY ACS AND SYNERGY Journal of the American College of Cardiology. 57: E1239. DOI: 10.1016/S0735-1097(11)61239-4 |
0.353 |
|
| 2011 |
Lin A, Looi K, Looi J, Chow K, Roberts F, White H, Webster M, Ellis C. Primary Percutaneous Coronary Intervention for all Patients with ST Elevation Myocardial Infarction—The Initial Experience at Auckland City Hospital 2006/2007 Heart, Lung and Circulation. 20: 396. DOI: 10.1016/J.HLC.2011.03.058 |
0.336 |
|
| 2010 |
Stebbins A, Mehta RH, Armstrong PW, Lee KL, Hamm C, Van de Werf F, James S, Toftegaard-Nielsen T, Seabra-Gomes R, White HD, Granger CB. A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. Circulation. Cardiovascular Interventions. 3: 414-22. PMID 20858863 DOI: 10.1161/CIRCINTERVENTIONS.109.925180 |
0.388 |
|
| 2010 |
Ellis C, Gamble G, Hamer A, Williams M, Matsis P, Elliott J, Devlin G, Richards M, White H. Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. The New Zealand Medical Journal. 123: 25-43. PMID 20717176 |
0.313 |
|
| 2010 |
Lansky AJ, Goto K, Cristea E, Fahy M, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Mehran R, Moses J, Leon M, et al. Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Circulation. Cardiovascular Interventions. 3: 308-16. PMID 20647564 DOI: 10.1161/Circinterventions.109.887604 |
0.423 |
|
| 2010 |
Kirtane AJ, Parise H, Mehran R, Moses JW, Fahy M, Bertrand ME, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Ware JH, Pocock SJ, Lansky AJ, et al. Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy). The American Journal of Cardiology. 106: 180-6. PMID 20599000 DOI: 10.1016/j.amjcard.2010.03.015 |
0.334 |
|
| 2010 |
Chin CT, Roe MT, Fox KA, Prabhakaran D, Marshall DA, Petitjean H, Lokhnygina Y, Brown E, Armstrong PW, White HD, Ohman EM. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. American Heart Journal. 160: 16-22.e1. PMID 20598967 DOI: 10.1016/J.Ahj.2010.04.022 |
0.376 |
|
| 2010 |
Simes RJ, O'Connell RL, Aylward PE, Varshavsky S, Diaz R, Wilcox RG, Armstrong PW, Granger CB, French JK, Van de Werf F, Marschner IC, Califf R, White HD. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. American Heart Journal. 159: 988-97. PMID 20569711 DOI: 10.1016/j.ahj.2009.12.044 |
0.364 |
|
| 2010 |
Steg PG, Kerner A, Mancini GBJ, Reynolds HR, Carvalho AC, Fridrich V, White HD, Forman SA, Lamas GA, Hochman JS, Buller CE. Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: A report from the randomized occluded artery trial Circulation. 121: 2724-2730. PMID 20547926 DOI: 10.1161/CIRCULATIONAHA.109.933200 |
0.384 |
|
| 2010 |
Wong CK, Gao W, Stewart RA, Benatar J, French JK, Aylward PE, White HD. aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction. European Heart Journal. 31: 1845-53. PMID 20513728 DOI: 10.1093/eurheartj/ehq161 |
0.333 |
|
| 2010 |
Cohen M, Levine GN, Pieper KS, Lan L, Antman EM, Aylward PE, White HD, Kleiman NS, Califf RM, Mahaffey KW. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 75: 928-35. PMID 20432399 DOI: 10.1002/Ccd.22340 |
0.317 |
|
| 2010 |
Nilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart (British Cardiac Society). 96: 838-42. PMID 20406769 DOI: 10.1136/hrt.2009.180182 |
0.314 |
|
| 2010 |
Goto K, Lansky AJ, Fahy M, Cristea E, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Mehran R, Stone GW. Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy. Circulation. 121: 853-62. PMID 20142447 DOI: 10.1161/CIRCULATIONAHA.109.877944 |
0.34 |
|
| 2010 |
Lopes RD, Starr A, Pieper CF, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Mahaffey KW, Armstrong PW, Harrington RA, White HD, Wallentin L, Granger CB. Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes. The American Journal of Medicine. 123: 134-40. PMID 20103022 DOI: 10.1016/j.amjmed.2009.09.015 |
0.36 |
|
| 2010 |
White HD, Aylward PE, Gallo R, Bode C, Steg G, Steinhubl SR, Montalescot G. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. American Heart Journal. 159: 110-116. PMID 20102875 DOI: 10.1016/J.Ahj.2009.10.034 |
0.322 |
|
| 2010 |
Yan RT, Yan AT, Mahaffey KW, White HD, Pieper K, Sun JL, Pepine CJ, Biasucci LM, Gulba DC, Lopez-Sendon J, Goodman SG. Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes. European Heart Journal. 31: 958-66. PMID 20034973 DOI: 10.1093/eurheartj/ehp548 |
0.339 |
|
| 2010 |
White HD. Strategies to minimize bleeding complications of percutaneous coronary intervention. Current Opinion in Cardiology. 24: 273-8. PMID 19474710 DOI: 10.1097/HCO.0b013e32832d1ea2 |
0.349 |
|
| 2010 |
Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ, Rao SV, Gallo R, Ducas J, Goodman SG, Antman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, et al. Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. International Journal of Cardiology. 144: 36-41. PMID 19406493 DOI: 10.1016/J.Ijcard.2009.03.119 |
0.355 |
|
| 2010 |
Nikolsky E, Mehran R, Magnus Ohman E, Bertrand ME, Michael Lincoff A, Moses JW, Cristea E, White HD, Fahy M, Lansky AJ, Stone GW. OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PRIOR CORONARY ARTERY BYPASS GRAFTING: ANALYSIS FROM THE ACUITY TRIAL Journal of the American College of Cardiology. 55: A190.E1777. DOI: 10.1016/S0735-1097(10)61778-0 |
0.349 |
|
| 2010 |
Chan MY, Sun J, Newby LK, White HD, Moliterno DJ, Theroux P, Ohman EM, Pieper KS, Giugliano RP, Armstrong PW, Califf RM, Van de Werf F, Harrington RA. TEMPORAL TRENDS OVER 15 YEARS IN CLINICAL TRIALS OF NON-ST ELEVATION ACUTE CORONARY SYNDROMES: MORE AGGRESSIVE TREATMENT YIELDS SIMILAR MORTALITY DESPITE HIGHER-RISK PROFILES Journal of the American College of Cardiology. 55: A136.E1278. DOI: 10.1016/S0735-1097(10)61279-X |
0.336 |
|
| 2010 |
Ambrosio G, Steinhubl SR, Gresele P, Tritto I, Bentivoglio M, Zuchi C, Cox DA, McLaurin BT, Moses JW, White HD, Feit F, Aylward PE, Colombo A, Darius H, Ebrahimi R, et al. IMPACT OF PRIOR CHRONIC ANTIPLATELET THERAPY ON SHORT- AND LONG-TERM ADVERSE EVENTS IN PATIENTS PRESENTING WITH AN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE ACUITY TRIAL Journal of the American College of Cardiology. 55: A113.E1059. DOI: 10.1016/S0735-1097(10)61060-1 |
0.316 |
|
| 2010 |
Chow K, Looi K, Looi J, Lin A, Lin C, Haliday S, Lee M, White H, Ellis C. Acute Coronary Syndrome Patients Treated with CABG Surgery: Suboptimal Use of Secondary Prevention Medications at Review 3 Years Later Heart, Lung and Circulation. 19: S20-S21. DOI: 10.1016/J.HLC.2010.06.711 |
0.3 |
|
| 2010 |
Lin C, Lin A, Looi J, Looi K, Chow K, Haliday S, Lee M, White H, Ellis C. Acute Coronary Syndrome Patients Treated with Percutaneous Coronary Intervention: Potential for Significant Socio-Economic Burden from Adverse Events Due to Poor Cholesterol Control at Review 3 Years Later Heart, Lung and Circulation. 19: S19-S20. DOI: 10.1016/J.HLC.2010.04.041 |
0.345 |
|
| 2009 |
Tjandrawidjaja MC, Fu Y, Westerhout CM, White HD, Todaro TG, Van de Werf F, Mahaffey KW, Wagner GS, Granger CB, Armstrong PW. Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction. European Heart Journal. 31: 573-81. PMID 19952006 DOI: 10.1093/eurheartj/ehp494 |
0.312 |
|
| 2009 |
Montalescot G, Gallo R, White HD, Cohen M, Steg PG, Aylward PEG, Bode C, Chiariello M, King SB, Harrington RA, Desmet WJ, Macaya C, Steinhubl SR. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention : 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial Jacc-Cardiovascular Interventions. 2: 1083-1091. PMID 19926048 DOI: 10.1016/J.Jcin.2009.08.016 |
0.346 |
|
| 2009 |
Nikolsky E, Stone GW, Kirtane AJ, Dangas GD, Lansky AJ, McLaurin B, Lincoff AM, Feit F, Moses JW, Fahy M, Manoukian SV, White HD, Ohman EM, Bertrand ME, Cox DA, et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Journal of the American College of Cardiology. 54: 1293-302. PMID 19778672 DOI: 10.1016/j.jacc.2009.07.019 |
0.353 |
|
| 2009 |
Wong CK, White HD. Cardiogenic shock from left ventricular dysfunction complicating an acute ST-elevation myocardial infarction The American Heart Hospital Journal. 7: 33-38. PMID 19742431 DOI: 10.15420/AHHJ.2009.7.1.33 |
0.346 |
|
| 2009 |
Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Journal of the American College of Cardiology. 54: 477-86. PMID 19628125 DOI: 10.1016/j.jacc.2009.03.063 |
0.383 |
|
| 2009 |
Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, Gersh BJ, Ohman EM, White HD, Moses JW, Ware JH, Lincoff AM, Stone GW. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. Journal of the American College of Cardiology. 53: 1965-72. PMID 19460609 DOI: 10.1016/j.jacc.2009.03.006 |
0.383 |
|
| 2009 |
Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald E. Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 An Application of the Classification System From the Universal Definition of Myocardial Infarction Circulation. 119: 2758-2764. PMID 19451347 DOI: 10.1161/Circulationaha.108.833665 |
0.4 |
|
| 2009 |
White HD. Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome. Expert Opinion On Drug Metabolism & Toxicology. 5: 529-38. PMID 19416088 DOI: 10.1517/17425250902845646 |
0.415 |
|
| 2009 |
Lansky AJ, Mehran R, Cristea E, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Stone GW. Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). The American Journal of Cardiology. 103: 1196-203. PMID 19406258 DOI: 10.1016/j.amjcard.2009.01.030 |
0.314 |
|
| 2009 |
Mehran R, Pocock SJ, Stone GW, Clayton TC, Dangas GD, Feit F, Manoukian SV, Nikolsky E, Lansky AJ, Kirtane A, White HD, Colombo A, Ware JH, Moses JW, Ohman EM. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. European Heart Journal. 30: 1457-66. PMID 19351691 DOI: 10.1093/eurheartj/ehp110 |
0.402 |
|
| 2009 |
Berry C, Pieper KS, White HD, Solomon SD, Van de Werf F, Velazquez EJ, Maggioni AP, Califf RM, Pfeffer MA, McMurray JJ. Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). European Heart Journal. 30: 1450-6. PMID 19346225 DOI: 10.1093/eurheartj/ehp102 |
0.41 |
|
| 2009 |
Wang TY, Zhang M, Fu Y, Armstrong PW, Newby LK, Gibson CM, Moliterno DJ, Van de Werf F, White HD, Harrington RA, Roe MT. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. American Heart Journal. 157: 716-23. PMID 19332201 DOI: 10.1016/j.ahj.2009.01.004 |
0.37 |
|
| 2009 |
Lopes RD, Alexander KP, Manoukian SV, Bertrand ME, Feit F, White HD, Pollack CV, Hoekstra J, Gersh BJ, Stone GW, Ohman EM. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Journal of the American College of Cardiology. 53: 1021-30. PMID 19298914 DOI: 10.1016/j.jacc.2008.12.021 |
0.367 |
|
| 2009 |
White HD. HORIZONS trial: a step forward for primary percutaneous coronary intervention. Expert Review of Cardiovascular Therapy. 7: 125-9. PMID 19210208 DOI: 10.1586/14779072.7.2.125 |
0.363 |
|
| 2009 |
Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, Cox DA, Lincoff AM, Ohman EM, White HD, Parise H, Leon MB, Stone GW. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation. 119: 687-98. PMID 19171852 DOI: 10.1161/CIRCULATIONAHA.108.804203 |
0.3 |
|
| 2009 |
Wong C, White HD. Prognostic Value of Lead V1 ST Elevation during Acute Inferior Myocardial Infarction Heart, Lung and Circulation. 18: S121-S122. DOI: 10.1016/J.HLC.2009.05.276 |
0.307 |
|
| 2009 |
Wong C, White HD. aVR ST Elevation: An Important but Neglected Sign in ST Elevation Acute Myocardial Infarction Heart, Lung and Circulation. 18: S109. DOI: 10.1016/J.HLC.2009.05.247 |
0.328 |
|
| 2008 |
Chan MY, Mahaffey KW, Sun LJ, Pieper KS, White HD, Aylward PE, Ferguson JJ, Califf RM, Roe MT. Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease. Jacc. Cardiovascular Interventions. 1: 369-78. PMID 19463332 DOI: 10.1016/j.jcin.2008.03.019 |
0.358 |
|
| 2008 |
Kruk M, Kadziela J, Reynolds HR, Forman SA, Sadowski Z, Barton BA, Mark DB, Maggioni AP, Leor J, Webb JG, Kapeliovich M, Marin-Neto JA, White HD, Lamas GA, Hochman JS. Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study. Jacc. Cardiovascular Interventions. 1: 511-20. PMID 19194534 DOI: 10.1016/j.jcin.2008.08.007 |
0.396 |
|
| 2008 |
Menon V, Pearte CA, Buller CE, Steg PG, Forman SA, White HD, Marino PN, Katritsis DG, Caramori P, Lasevitch R, Loboz-Grudzien K, Zurakowski A, Lamas GA, Hochman JS. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. European Heart Journal. 30: 183-91. PMID 19028780 DOI: 10.1093/eurheartj/ehn486 |
0.36 |
|
| 2008 |
Alpert JS, Thygesen K, White HD, Jaffe AS. Implications of the universal definition of myocardial infarction. Nature Clinical Practice. Cardiovascular Medicine. 5: 678-9. PMID 18779833 DOI: 10.1038/ncpcardio1329 |
0.316 |
|
| 2008 |
Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation. 118: 1335-46. PMID 18779444 DOI: 10.1161/CIRCULATIONAHA.108.767772 |
0.391 |
|
| 2008 |
White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. Journal of the American College of Cardiology. 52: 807-14. PMID 18755342 DOI: 10.1016/j.jacc.2008.05.036 |
0.359 |
|
| 2008 |
White HD, Chew DP. Acute myocardial infarction. Lancet (London, England). 372: 570-84. PMID 18707987 DOI: 10.1016/S0140-6736(08)61237-4 |
0.373 |
|
| 2008 |
White HD. Will new higher-precision troponins lead to clarity or confusion? Current Opinion in Cardiology. 23: 292-5. PMID 18520710 DOI: 10.1097/HCO.0b013e3283050808 |
0.357 |
|
| 2008 |
White HD, Chew DP, Hoekstra JW, Miller CD, Pollack CV, Feit F, Lincoff AM, Bertrand M, Pocock S, Ware J, Ohman EM, Mehran R, Stone GW. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. Journal of the American College of Cardiology. 51: 1734-41. PMID 18452778 DOI: 10.1016/J.Jacc.2007.12.052 |
0.337 |
|
| 2008 |
Chew DP, Mahaffey KW, White HD, Huang Z, Hoekstra JW, Ferguson JJ, Califf RM, Aylward PE. Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict. American Heart Journal. 155: 841-7. PMID 18440330 DOI: 10.1016/j.ahj.2007.12.002 |
0.336 |
|
| 2008 |
Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal. 155: 706-11. PMID 18371480 DOI: 10.1016/j.ahj.2007.11.016 |
0.35 |
|
| 2008 |
Thygesen K, Alpert JS, White HD. [Universal definition of the myocardial infarction]. Kardiologia Polska. 66: 47-62. PMID 18363225 |
0.304 |
|
| 2008 |
Mehta RH, Rao SV, Ohman EM, Bates ER, Marcucci G, Zhang M, Pieper KS, Armstrong PW, White HD, Van de Werf F, Califf RM, Granger CB. Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb. European Heart Journal. 29: 880-7. PMID 18334473 DOI: 10.1093/eurheartj/ehn100 |
0.333 |
|
| 2008 |
Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart (British Cardiac Society). 94: 867-73. PMID 18332062 DOI: 10.1136/hrt.2007.134486 |
0.311 |
|
| 2008 |
Chew DP, Huang Z, Pieper KS, White H, Mahaffey KW, Ferguson JJ, Califf RM, Aylward PG. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy. American Heart Journal. 155: 239-44. PMID 18215592 DOI: 10.1016/j.ahj.2007.10.002 |
0.376 |
|
| 2008 |
Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. Journal of General Internal Medicine. 23: 310-6. PMID 18196350 DOI: 10.1007/S11606-007-0498-4 |
0.385 |
|
| 2008 |
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Journal of the American College of Cardiology. 50: 2173-95. PMID 18036459 DOI: 10.1016/j.jacc.2007.09.011 |
0.304 |
|
| 2008 |
Bissessor N, White H. Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction. Vascular Health and Risk Management. 3: 425-30. PMID 17969373 |
0.318 |
|
| 2008 |
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. European Heart Journal. 28: 2525-38. PMID 17951287 DOI: 10.1093/EURHEARTJ/EHM355 |
0.304 |
|
| 2008 |
Gabriel RS, White HD. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis. Expert Review of Cardiovascular Therapy. 5: 851-7. PMID 17867915 DOI: 10.1586/14779072.5.5.851 |
0.396 |
|
| 2008 |
Wong C, White HD. Enoxaparin: a perspective on its use for coronary artery disease Aging Health. 4: 579-591. DOI: 10.2217/1745509X.4.6.579 |
0.378 |
|
| 2008 |
Thygesen K, Alpert J, White H. UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION Rational Pharmacotherapy in Cardiology. 4: 91-105. DOI: 10.20996/1819-6446-2008-4-5-91-105 |
0.304 |
|
| 2008 |
Raj G, Legget M, Stewart R, White H, Ruygrok P. AN EARLY INVASIVE STRATEGY IN ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROMES (ACS)—ARE WE MAKING A DIFFERENCE? Heart, Lung and Circulation. 17: S20. DOI: 10.1016/J.HLC.2008.03.045 |
0.336 |
|
| 2007 |
Berger JS, Stebbins A, Granger CB, Ohman EM, Armstrong PW, Van de Werf F, White HD, Simes RJ, Harrington RA, Califf RM, Peterson ED. Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy. Circulation. 117: 192-9. PMID 18086929 DOI: 10.1161/CIRCULATIONAHA.107.729558 |
0.355 |
|
| 2007 |
Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet J, Steinhubl SR, Montalescot G. Intravenous Low-Molecular-Weight Heparins Compared With Unfractionated Heparin in Percutaneous Coronary Intervention: Quantitative Review of Randomized Trials Jama Internal Medicine. 167: 2423-2430. PMID 18071163 DOI: 10.1001/Archinte.167.22.2423 |
0.329 |
|
| 2007 |
Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. Jama. 298: 2497-506. PMID 18056903 DOI: 10.1001/jama.298.21.2497 |
0.383 |
|
| 2007 |
Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, et al. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation. 116: 2669-77. PMID 18025532 DOI: 10.1161/Circulationaha.107.690081 |
0.395 |
|
| 2007 |
Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, et al. Universal definition of myocardial infarction. Circulation. 116: 2634-53. PMID 17951284 DOI: 10.1161/CIRCULATIONAHA.107.187397 |
0.304 |
|
| 2007 |
Wong CK, White HD. Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 7: 249-57. PMID 17696566 DOI: 10.2165/00129784-200707040-00003 |
0.364 |
|
| 2007 |
Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 115: 2570-89. PMID 17502591 DOI: 10.1161/CIRCULATIONAHA.107.182616 |
0.34 |
|
| 2007 |
Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 115: 2549-69. PMID 17502590 DOI: 10.1161/Circulationaha.107.182615 |
0.346 |
|
| 2007 |
White HD, Braunwald E, Murphy SA, Jacob AJ, Gotcheva N, Polonetsky L, Antman EM. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. European Heart Journal. 28: 1066-71. PMID 17456482 DOI: 10.1093/Eurheartj/Ehm081 |
0.313 |
|
| 2007 |
Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB, Ohman EM, Stone GW. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. Journal of the American College of Cardiology. 49: 1362-8. PMID 17394970 DOI: 10.1016/j.jacc.2007.02.027 |
0.352 |
|
| 2007 |
Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet (London, England). 369: 907-19. PMID 17368152 DOI: 10.1016/S0140-6736(07)60450-4 |
0.352 |
|
| 2007 |
Stephenson K, Skali H, McMurray JJV, Velazquez EJ, Aylward PG, Kober L, Van de Werf F, White HD, Pieper KS, Califf RM, Solomon SD, Pfeffer MA. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience Heart Rhythm. 4: 308-313. PMID 17341394 DOI: 10.1016/j.hrthm.2006.11.021 |
0.302 |
|
| 2007 |
Stone GW, Bertrand ME, Moses JW, Ohman EM, Lincoff AM, Ware JH, Pocock SJ, McLaurin BT, Cox DA, Jafar MZ, Chandna H, Hartmann F, Leisch F, Strasser RH, Desaga M, ... ... White HD, et al. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. Jama. 297: 591-602. PMID 17299194 DOI: 10.1001/jama.297.6.591 |
0.312 |
|
| 2007 |
Dieker HJ, French JK, Joziasse IC, Brouwer MA, Elliott J, West TM, Webber BJ, Verheugt FW, White HD. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction. American Heart Journal. 153: 66.e1-8. PMID 17174639 DOI: 10.1016/j.ahj.2006.10.006 |
0.372 |
|
| 2007 |
Mehta RH, Califf RM, Garg J, White HD, Van De Werf F, Armstrong PW, Pieper KS, Topol EJ, Granger CB. The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction European Heart Journal. 28: 415-424. PMID 17040928 DOI: 10.1093/eurheartj/ehl329 |
0.331 |
|
| 2006 |
White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ, Califf RM. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. American Heart Journal. 152: 1042-50. PMID 17161049 DOI: 10.1016/J.Ahj.2006.08.002 |
0.424 |
|
| 2006 |
Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, et al. Bivalirudin for patients with acute coronary syndromes. The New England Journal of Medicine. 355: 2203-16. PMID 17124018 DOI: 10.1056/NEJMoa062437 |
0.346 |
|
| 2006 |
Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, et al. Coronary intervention for persistent occlusion after myocardial infarction. The New England Journal of Medicine. 355: 2395-407. PMID 17105759 DOI: 10.1056/NEJMoa066139 |
0.384 |
|
| 2006 |
Westerhout CM, Hernández AV, Steyerberg EW, Bueno H, White H, Théroux P, Moliterno DJ, Armstrong PW, Califf RM, Wallentin LC, Simoons ML, Boersma E. Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. European Heart Journal. 27: 2956-61. PMID 17093039 DOI: 10.1093/EURHEARTJ/EHL356 |
0.312 |
|
| 2006 |
Hernández AV, Westerhout CM, Steyerberg EW, Ioannidis JP, Bueno H, White H, Theroux P, Moliterno DJ, Armstrong PW, Califf RM, Wallentin LC, Simoons ML, Boersma E. Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups. Heart (British Cardiac Society). 93: 450-5. PMID 17065179 DOI: 10.1136/hrt.2006.098657 |
0.303 |
|
| 2006 |
Cohen M, Mahaffey KW, Pieper K, Pollack CV, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ. A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial. Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes Journal of the American College of Cardiology. 48: 1346-1354. PMID 17010793 DOI: 10.1016/J.Jacc.2006.05.058 |
0.314 |
|
| 2006 |
Reed SD, McMurray JJ, Velazquez EJ, Schulman KA, Califf RM, Kober L, Maggioni AP, Van de Werf F, White HD, Diaz R, Mareev V, Murin J. Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal. 152: 500-8. PMID 16923421 DOI: 10.1016/J.AHJ.2006.02.032 |
0.361 |
|
| 2006 |
Wong CK, Gao W, Stewart RA, van Pelt N, French JK, Aylward PE, White HD. Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy. Circulation. 114: 783-9. PMID 16908761 DOI: 10.1161/CIRCULATIONAHA.106.639039 |
0.328 |
|
| 2006 |
Janardhanan R, Kenchaiah S, Velazquez EJ, Park Y, McMurray JJ, Weaver WD, Finn PV, White HD, Marin-Neto JA, O'Connor C, Pfeffer MA, Califf RM, Solomon SD. Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. American Heart Journal. 152: 183-9. PMID 16824854 DOI: 10.1016/J.AHJ.2005.11.013 |
0.361 |
|
| 2006 |
Tonkin AM, Eckermann S, White H, Friedlander D, Glasziou P, Magnus P, Kirby A, Mulray S, Denton M, Sallaberger M, Hunt D, Simes J. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study. American Heart Journal. 151: 1305-12. PMID 16781242 DOI: 10.1016/J.AHJ.2005.07.014 |
0.314 |
|
| 2006 |
Alexander KP, Newby LK, Bhapkar MV, White HD, Hochman JS, Pfisterer ME, Moliterno DJ, Peterson ED, Van De Werf F, Armstrong PW, Califf RM. International variation in invasive care of the elderly with acute coronary syndromes European Heart Journal. 27: 1558-1564. PMID 16760200 DOI: 10.1093/eurheartj/ehl067 |
0.339 |
|
| 2006 |
Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. Jama. 295: 2511-5. PMID 16757723 DOI: 10.1001/JAMA.295.21.2511 |
0.31 |
|
| 2006 |
Raffel OC, White HD. Drug insight: Statin use in the elderly. Nature Clinical Practice. Cardiovascular Medicine. 3: 318-28. PMID 16729010 DOI: 10.1038/ncpcardio0558 |
0.373 |
|
| 2006 |
Edmond JJ, French JK, Stewart RA, Aylward PA, De Pasquale CG, Williams BF, O'Connell RL, Simes RJ, White HD. Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques. The American Journal of Cardiology. 97: 947-51. PMID 16563892 DOI: 10.1016/j.amjcard.2005.10.031 |
0.393 |
|
| 2006 |
Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. The New England Journal of Medicine. 354: 1477-88. PMID 16537665 DOI: 10.1056/Nejmoa060898 |
0.32 |
|
| 2006 |
McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van De Werf F, Califf R, Pfeffer M. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: An analysis of the valsartan in acute myocardial infarction trial (VALIANT) Journal of the American College of Cardiology. 47: 726-733. PMID 16487836 DOI: 10.1016/j.jacc.2005.09.055 |
0.326 |
|
| 2006 |
White H, Ellis C. PHARMAC and lack of funding for clopidogrel. The New Zealand Medical Journal. 119: U1808. PMID 16462916 |
0.34 |
|
| 2006 |
Patel MR, Meine TJ, Lindblad L, Griffin J, Granger CB, Becker RC, Van de Werf F, White H, Califf RM, Harrington RA. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. American Heart Journal. 151: 316-22. PMID 16442893 DOI: 10.1016/J.AHJ.2005.04.014 |
0.346 |
|
| 2006 |
Orlandini A, Díaz R, Wojdyla D, Pieper K, Van De Werf F, Granger CB, Harrington RA, Boersma E, Califf RM, Armstrong P, White H, Simes J, Paolasso E. Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes European Heart Journal. 27: 527-533. PMID 16410369 DOI: 10.1093/eurheartj/ehi701 |
0.32 |
|
| 2006 |
White HD. Hirudin is modestly more effective than heparin in the treatment of acute coronary syndromes. Evidence-Based Cardiovascular Medicine. 1: 19. PMID 16379689 DOI: 10.1016/S1361-2611(97)80088-7 |
0.317 |
|
| 2006 |
Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Roe MT, Ohman EM, Granger CB, Armstrong PW, Harrington RA, White HD, Simoons ML, Newby LK, Califf RM, Topol EJ. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. American Heart Journal. 151: 16-24. PMID 16368286 DOI: 10.1016/j.ahj.2005.01.045 |
0.323 |
|
| 2006 |
Wong CK, Stewart RA, Gao W, French JK, Raffel C, White HD. Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. European Heart Journal. 27: 21-8. PMID 16269419 DOI: 10.1093/eurheartj/ehi622 |
0.304 |
|
| 2006 |
Wong CK, White HD. Implications of the new definition of myocardial infarction. Postgraduate Medical Journal. 81: 552-5. PMID 16143682 DOI: 10.1136/pgmj.2005.035071 |
0.39 |
|
| 2006 |
Chew DP, Aylward P, White HD. Facilitated percutaneous coronary intervention: is this strategy ready for implementation? Current Cardiology Reports. 7: 235-41. PMID 15987619 DOI: 10.1007/S11886-005-0043-1 |
0.356 |
|
| 2005 |
Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin - Outcomes at 6 months and 1 year in the SYNERGY trial Jama. 294: 2594-2600. PMID 16304073 DOI: 10.1001/Jama.294.20.2594 |
0.318 |
|
| 2005 |
White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation. 112: 3391-9. PMID 16301343 DOI: 10.1161/CIRCULATIONAHA.105.551143 |
0.338 |
|
| 2005 |
Hochman JS, Lamas GA, Knatterud GL, Buller CE, Dzavik V, Mark DB, Reynolds HR, White HD. Design and methodology of the Occluded Artery Trial (OAT). American Heart Journal. 150: 627-42. PMID 16209957 DOI: 10.1016/J.AHJ.2005.07.002 |
0.369 |
|
| 2005 |
White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, Wong CK, Stewart JT, Aylward PE, Wong SC, Hochman JS. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 112: 1992-2001. PMID 16186436 DOI: 10.1161/CIRCULATIONAHA.105.540948 |
0.376 |
|
| 2005 |
Kleiman NS, White HD. The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes Heart. 91: 1121-1123. PMID 16103531 DOI: 10.1136/hrt.2004.056085 |
0.394 |
|
| 2005 |
Brener SJ, Lincoff AM, Bates ER, Jia G, Armstrong PW, Guetta V, Hochman JS, Savonitto S, Wilcox RG, White HD, Topol EJ. The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial. American Heart Journal. 150: 89-93. PMID 16084153 DOI: 10.1016/j.ahj.2005.01.030 |
0.385 |
|
| 2005 |
Meine TJ, Al-Khatib SM, Alexander JH, Granger CB, White HD, Kilaru R, Williams K, Ohman EM, Topol E, Califf RM. Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. American Heart Journal. 149: 670-4. PMID 15990751 DOI: 10.1016/J.AHJ.2004.07.035 |
0.329 |
|
| 2005 |
Solomon SD, Zelenkofske S, McMurray JJV, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van De Werf F, Pieper K, Califf RM, Pfeffer MA. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both New England Journal of Medicine. 352: 2581-2588. PMID 15972864 DOI: 10.1056/NEJMoa043938 |
0.304 |
|
| 2005 |
Mahaffey KW, Roe MT, Kilaru R, French JK, Alexander JH, Berdan LG, Van De Werf F, Simoons ML, Weaver WD, White HD, Lincoff AM, Kleiman NS, Topol EJ, Harrington RA. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. The American Journal of Cardiology. 95: 1404-8. PMID 15950560 DOI: 10.1016/J.AMJCARD.2005.02.005 |
0.409 |
|
| 2005 |
Mehta RH, Califf RM, Garg J, Pieper KS, Alexander JH, Moliterno DJ, Van De Werf F, Ohman EM, White HD, Topol EJ, Granger CB. Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy American Journal of Cardiology. 95: 1371-1375. PMID 15904648 DOI: 10.1016/j.amjcard.2005.01.087 |
0.332 |
|
| 2005 |
Antman EM, Morrow DA, McCabe CH, Jiang F, White HD, Fox KA, Sharma D, Chew P, Braunwald E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). American Heart Journal. 149: 217-26. PMID 15846258 DOI: 10.1016/J.Ahj.2004.08.038 |
0.334 |
|
| 2005 |
Wong CK, White HD. Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes. European Heart Journal. 26: 851-2. PMID 15781432 DOI: 10.1093/EURHEARTJ/EHI214 |
0.316 |
|
| 2005 |
Gersh BJ, Stone GW, White HD, Holmes DR. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? Jama. 293: 979-86. PMID 15728169 DOI: 10.1001/JAMA.293.8.979 |
0.368 |
|
| 2005 |
Mehta RH, Granger CB, Alexander KP, Bossone E, White HD, Sketch MH. Reperfusion strategies for acute myocardial infarction in the elderly: Benefits and risks Journal of the American College of Cardiology. 45: 471-478. PMID 15708688 DOI: 10.1016/j.jacc.2004.10.065 |
0.34 |
|
| 2005 |
Labinaz M, Mathias J, Pieper K, Granger CB, Lincoff AM, Moliterno DJ, Van De Werf F, Simes J, White HD, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: A pooled analysis of three randomized clinical trials European Heart Journal. 26: 128-136. PMID 15618068 DOI: 10.1093/eurheartj/ehi061 |
0.383 |
|
| 2004 |
Parsons E, Newby LK, Bhapkar MV, Alexander KP, White HD, Shah SH, Bushnell CD, Califf RM. Postmenopausal hormone use in women with acute coronary syndromes. Journal of Women's Health (2002). 13: 863-71. PMID 15671702 DOI: 10.1089/jwh.2004.13.863 |
0.311 |
|
| 2004 |
White HD, Palmeri ST, Sleeper LA, French JK, Wong CK, Lowe AM, Crapo JW, Koller PT, Baran KW, Boland JL, Hochman JS, Wagner GS. Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial. American Heart Journal. 148: 810-7. PMID 15523311 DOI: 10.1016/j.ahj.2004.05.012 |
0.306 |
|
| 2004 |
Stone GW, Bertrand M, Colombo A, Dangas G, Farkouh ME, Feit F, Lansky AJ, Lincoff AM, Mehran R, Moses JW, Ohman M, White HD. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. American Heart Journal. 148: 764-75. PMID 15523305 DOI: 10.1016/j.ahj.2004.04.036 |
0.425 |
|
| 2004 |
Lemos JAd, Blazing MA, Wiviott SD, Brady WE, White HD, Fox KAA, Palmisano J, Ramsey KE, Bilheimer DW, Lewis EF, Pfeffer M, Califf RM, Braunwald E. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial European Heart Journal. 25: 1688-1694. PMID 15451146 DOI: 10.1016/J.Ehj.2004.06.028 |
0.317 |
|
| 2004 |
Kassem-Moussa H, Mahaffey KW, Graffagnino C, Tasissa G, Sila CA, Simes RJ, White HD, Califf RM, Bhapkar MV, Newby LK. Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome. American Heart Journal. 148: 439-46. PMID 15389230 DOI: 10.1016/J.AHJ.2004.01.028 |
0.303 |
|
| 2004 |
Ellis C, Devlin G, Matsis P, Elliott J, Williams M, Gamble G, Mann S, French J, White H. Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. The New Zealand Medical Journal. 117: U954. PMID 15326507 |
0.304 |
|
| 2004 |
Ellis C, Gamble G, French J, Devlin G, Matsis P, Elliott J, Mann S, Williams M, White H. Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit. The New Zealand Medical Journal. 117: U953. PMID 15326506 |
0.342 |
|
| 2004 |
Blazing MA, De Lemos JA, White HD, Fox KAA, Verheugt FWA, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, et al. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial Journal of the American Medical Association. 292: 55-64. PMID 15238591 DOI: 10.1001/Jama.292.1.55 |
0.377 |
|
| 2004 |
Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, ... ... White H, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. Jama. 292: 45-54. PMID 15238590 DOI: 10.1001/jama.292.1.45 |
0.379 |
|
| 2004 |
French JK, Edmond JJ, Gao W, White HD, Eikelboom JW. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 4: 107-15. PMID 15049722 DOI: 10.2165/00129784-200404020-00004 |
0.372 |
|
| 2004 |
Merry AF, Raudkivi PJ, Middleton NG, McDougall JM, Nand P, Mills BP, Webber BJ, Frampton CM, White HD. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. The Annals of Thoracic Surgery. 77: 925-31; discussion 9. PMID 14992900 DOI: 10.1016/j.athoracsur.2003.09.061 |
0.301 |
|
| 2004 |
White HD, Willerson JT. We must use the knowledge that we have to treat patients with acute coronary syndromes. Circulation. 109: 698-700. PMID 14970103 DOI: 10.1161/01.CIR.0000116395.00932.EA |
0.328 |
|
| 2004 |
Oliveira GB, Kristin Newby L, Lindblad L, Piegas LS, Verheught FW, Harrington RA, Hochman JS, White HD, Werf FVd, Granger CB. 1042-82 White blood cell count predicts higher risk of intermediate-term outcomes in patients stabilized after acute coronary syndromes: Observations from the SYMPHONY and 2ndSYMPHONY trials Journal of the American College of Cardiology. 43: A258. DOI: 10.1016/S0735-1097(04)91098-4 |
0.316 |
|
| 2004 |
Tang W, Velazquez E, Kilaru R, Maroo A, White H, Kober L, Rouleau J, McMurray J, Califf R, Francis G. Patterns and outcomes of revascularization in patients with heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction: observations from the VALIANT registry Journal of Cardiac Failure. 10: S104. DOI: 10.1016/J.CARDFAIL.2004.06.321 |
0.302 |
|
| 2004 |
Blazing M, de Lemos J, White H. Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes. who receive tirofiban and aspirin Acc Current Journal Review. 13: 9. DOI: 10.1016/J.ACCREVIEW.2004.08.005 |
0.345 |
|
| 2003 |
Newby LK, Bhapkar MV, White HD, Moliterno DJ, LaPointe NM, Kandzari DE, Verheugt FW, Kramer JM, Armstrong PW, Califf RM. Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation. Journal of Thrombosis and Thrombolysis. 16: 119-28. PMID 15087598 DOI: 10.1023/B:THRO.0000024050.78728.35 |
0.321 |
|
| 2003 |
Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Krzeminska-Pakula M, Danchin N, White HD, Santopinto J, Bigonzi F, Hecquet C, Vittori L. The Safety and Efficacy of Subcutaneous Enoxaparin Versus Intravenous Unfractionated Heparin and Tirofiban Versus Placebo in the Treatment of Acute ST-Segment Elevation Myocardial Infarction Patients Ineligible for Reperfusion (TETAMI): A Randomized Trial Journal of the American College of Cardiology. 42: 1348-1356. PMID 14563573 DOI: 10.1016/S0735-1097(03)01040-4 |
0.336 |
|
| 2003 |
Velazquez EJ, Pfeffer MA, McMurray JV, Maggioni AP, Rouleau JL, Van de Werf F, Kober L, White HD, Swedberg K, Leimberger JD, Gallo P, Sellers MA, Edwards S, Henis M, Califf RM. VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context. European Journal of Heart Failure. 5: 537-44. PMID 12921816 DOI: 10.1016/S1388-9842(03)00112-0 |
0.346 |
|
| 2003 |
Tolleson TR, Newby LK, Harrington RA, Bhapkar MV, Verheugt FW, Berger PB, Moliterno DJ, White HD, Ohman EM, Van de Werf F, Topol EJ, Califf RM. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). The American Journal of Cardiology. 92: 330-3. PMID 12888148 DOI: 10.1016/S0002-9149(03)00641-6 |
0.359 |
|
| 2003 |
Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, Davidoff R, Boland J, Modur S, Forman R, Hochman JS. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. Journal of the American College of Cardiology. 41: 1273-9. PMID 12706920 DOI: 10.1016/S0735-1097(03)00120-7 |
0.31 |
|
| 2003 |
Hyde TA, French JK, Wong CK, Edwards C, Whitlock RM, White HD. Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes. Heart (British Cardiac Society). 89: 490-5. PMID 12695448 DOI: 10.1136/heart.89.5.490 |
0.326 |
|
| 2003 |
Al-Khatib SM, Stebbins AL, Califf RM, Lee KL, Granger CB, White HD, Armstrong PW, Topol EJ, Ohman EM. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. American Heart Journal. 145: 515-21. PMID 12660676 DOI: 10.1067/MHJ.2003.170 |
0.414 |
|
| 2003 |
Eikelboom J, White H, Yusuf S. The evolving role of direct thrombin inhibitors in acute coronary syndromes. Journal of the American College of Cardiology. 41: 70-78. PMID 12644344 DOI: 10.1016/S0735-1097(02)02687-6 |
0.321 |
|
| 2003 |
Newby LK, Bhapkar MV, White HD, Topol EJ, Dougherty FC, Harrington RA, Smith MC, Asarch LF, Califf RM. Predictors of 90-day outcome in patients stabilized after acute coronary syndromes. European Heart Journal. 24: 172-81. PMID 12573274 DOI: 10.1016/S0195-668X(02)00325-1 |
0.346 |
|
| 2003 |
Heeschen C, Hamm CW, Laufs U, Böhm M, Snapinn S, White HD. Withdrawal of statins in patients with acute coronary syndromes Circulation. 107. PMID 12551886 DOI: 10.1161/01.Cir.0000050552.32300.93 |
0.332 |
|
| 2003 |
Wong CK, French JK, Gao W, White HD. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase. American Heart Journal. 145: 95-102. PMID 12514660 DOI: 10.1067/MHJ.2003.64 |
0.33 |
|
| 2003 |
O'Shea JC, Wilcox RG, Skene AM, Stebbins AL, Granger CB, Armstrong PW, Bode C, Ardissino D, Emanuelsson H, Aylward PE, White HD, Sadowski Z, Topol EJ, Califf RM, Ohman EM. Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone. The American Journal of Cardiology. 90: 1374-7. PMID 12480048 DOI: 10.1016/S0002-9149(02)02876-X |
0.307 |
|
| 2003 |
White HD, Chew DP. Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions. Expert Opinion On Pharmacotherapy. 3: 777-88. PMID 12036417 DOI: 10.1517/14656566.3.6.777 |
0.41 |
|
| 2003 |
Simes J, White HD, Marschner IC, Varshavsky S, Diaz R, French JK, Aylward P. International differences in patients, care and outcomes associated with acute myocardial infarction (AMI): the HERO-2 trial Heart Lung and Circulation. 12. DOI: 10.1046/J.1443-9506.2003.0120X.X |
0.333 |
|
| 2003 |
Tanguay J, Krucoff MW, Gibbons RJ, Chavez E, Liprandi AS, Molina-Viamonte V, Aylward PE, Lopez-Sendon JL, Holloway D, Shields K, Yu JS, Loh E, Baran KW, Bethala VK, Vahanian A, ... White HD, et al. Efficacy of a novel P-selectin antagonist, rPSGL-Ig for reperfusion therapy in acute myocardial infarction: The RAPSODY trial Journal of the American College of Cardiology. 41: 404-405. DOI: 10.1016/S0735-1097(03)81179-8 |
0.312 |
|
| 2003 |
Wong C, White HD. Usefulness of concordant ST elevation and V1-3 st depression in risk stratifying patients with presumed acute myocardial infarction and left bundle branch block Journal of the American College of Cardiology. 41: 122-123. DOI: 10.1016/S0735-1097(03)80745-3 |
0.305 |
|
| 2003 |
Feit F, Bittl JA, Michael Lincoff A, Chew DP, Kleiman NS, Wallentin L, White HD, Orniston J, Robson R, Aylward PE, Attubato MJ. Bivalirudin reduces ischemic and hemorrhagic complications of percutaneous coronary intervention: Pooled data from 10 prospective studies in 6,134 patients Journal of the American College of Cardiology. 41: 25. DOI: 10.1016/S0735-1097(03)80106-7 |
0.32 |
|
| 2002 |
Mukherjee D, Mahaffey KW, Moliterno DJ, Harrington RA, Yadav JS, Pieper KS, Gallup D, Dyke C, Roe MT, Berdan L, Lauer MS, Mänttäri M, White HD, Califf RM, Topol EJ. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: Results from platelet IIb/IIIa antagonist for the reduction of acute coronary syndrome events in a Global Organization Network B (PARAGON B) American Heart Journal. 144: 995-1002. PMID 12486423 DOI: 10.1067/mhj.2002.126118 |
0.329 |
|
| 2002 |
Juergens CP, White HD, Belardi JA, Macaya C, Soler-Soler J, Meyer BJ, Levy RD, Bunt T, Menten J, Herrmann HC, Adgey AA, Tarnesby G. A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement. Clinical Therapeutics. 24: 1332-44. PMID 12240783 DOI: 10.1016/S0149-2918(02)80037-6 |
0.353 |
|
| 2002 |
Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. Heart (British Cardiac Society). 88: 357-62. PMID 12231591 DOI: 10.1136/heart.88.4.357 |
0.366 |
|
| 2002 |
Cohen M, Théroux P, Borzak S, Frey MJ, White HD, Van Mieghem W, Senatore F, Lis J, Mukherjee R, Harris K, Bigonzi F. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. American Heart Journal. 144: 470-7. PMID 12228784 DOI: 10.1067/Mhj.2002.126115 |
0.354 |
|
| 2002 |
Wong CK, French JK, Krucoff MW, Gao W, Aylward PE, White HD. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. European Heart Journal. 23: 1449-55. PMID 12208225 DOI: 10.1053/EUHJ.2002.3263 |
0.305 |
|
| 2002 |
Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Moliterno DJ, Heeschen C, Hamm CW, Robbins MA, Kleiman NS, Théroux P, White HD, Topol EJ. Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. European Heart Journal. 23: 1441-8. PMID 12208224 DOI: 10.1053/euhj.2002.3160 |
0.305 |
|
| 2002 |
Al-Khatib SM, Granger CB, Huang Y, Lee KL, Califf RM, Simoons ML, Armstrong PW, Van de Werf F, White HD, Simes RJ, Moliterno DJ, Topol EJ, Harrington RA. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation. 106: 309-12. PMID 12119245 DOI: 10.1161/01.CIR.0000022692.49934.E3 |
0.397 |
|
| 2002 |
Anderson RD, White HD, Ohman EM, Wagner GS, Krucoff MW, Armstrong PW, Weaver WD, Gibler WB, Stebbins AL, Califf RM, Topol EJ. Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries. American Heart Journal. 144: 81-8. PMID 12094192 DOI: 10.1067/mhj.2002.123319 |
0.381 |
|
| 2002 |
Wong CK, French JK, Gao W, White HD. Relation of initial platelet counts to Thrombolysis In Myocardial Infarction-3 flow rates at 90 minutes after commencing fibrinolytic therapy in patients with acute myocardial infarction. The American Journal of Cardiology. 90: 54-7. PMID 12088782 DOI: 10.1016/S0002-9149(02)02388-3 |
0.327 |
|
| 2002 |
Heeschen C, Hamm CW, Laufs U, Snapinn S, Böhm M, White HD. Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation. 105: 1446-1452. PMID 11914253 DOI: 10.1161/01.Cir.0000012530.68333.C8 |
0.375 |
|
| 2002 |
French JK, Andrews J, Manda SO, Stewart RA, McTigue JJ, White HD. Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction. American Heart Journal. 143: 265-71. PMID 11835029 DOI: 10.1067/MHJ.2002.120147 |
0.308 |
|
| 2002 |
Boersma E, Harrington RA, Moliterno DJ, White H, Théroux P, Van de Werf F, de Torbal A, Armstrong PW, Wallentin LC, Wilcox RG, Simes J, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (London, England). 359: 189-98. PMID 11812552 DOI: 10.1016/S0140-6736(02)07442-1 |
0.36 |
|
| 2002 |
White HD, Wong CK. Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes European Heart Journal. 23: 187-191. PMID 11792130 DOI: 10.1053/euhj.2001.2904 |
0.36 |
|
| 2002 |
Savonitto S, Granger CB, Ardissino D, Gardner L, Cavallini C, Galvani M, Ottani F, White HD, Armstrong PW, Ohman EM, Pieper KS, Califf RM, Topol EJ. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. Journal of the American College of Cardiology. 39: 22-9. PMID 11755282 DOI: 10.1016/S0735-1097(01)01706-5 |
0.307 |
|
| 2002 |
White H. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet (London, England). 358: 1855-63. PMID 11741625 DOI: 10.1016/S0140-6736(01)06887-8 |
0.375 |
|
| 2002 |
Roe MT, Granger CB, Puma JA, Hellkamp AS, Hochman JS, Ohman EM, White HD, Van de Werf F, Armstrong PW, Ellis SG, Califf RM, Topol EJ. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. The American Journal of Cardiology. 88: 1403-6, A6. PMID 11741559 DOI: 10.1016/S0002-9149(01)02119-1 |
0.363 |
|
| 2002 |
Simes J, White HD, Marschner IC, Varshavsky S, Diaz R, Wilcox RG, Armstrong PW, Granger CB, French JK, Van de Werf F, Aylward PE. International differences in patients, care, and outcomes associated with acute myocardial infarction: the hero-2 trial Journal of the American College of Cardiology. 39: 280. DOI: 10.1016/S0735-1097(02)81256-6 |
0.327 |
|
| 2001 |
Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S, Forman R, et al. One-year survival following early revascularization for cardiogenic shock Journal of the American Medical Association. 285: 190-192. PMID 11176812 DOI: 10.1001/JAMA.285.2.190 |
0.313 |
|
| 2000 |
Cohen M, Maritz F, Gensini GF, Danchin N, Timerman A, Huber K, Gurfinkel EP, White H, Fox KAA, Vittori L, Le-Louer V, Bigonzi F. The TETAMI trial: The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: Methods and design Journal of Thrombosis and Thrombolysis. 10: 241-246. PMID 11122544 DOI: 10.1023/A:1026543107533 |
0.313 |
|
| 2000 |
Webb JG, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, White HD, Hochman JS. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Journal of the American College of Cardiology. 36: 1084-90. PMID 10985709 DOI: 10.1016/S0735-1097(00)00876-7 |
0.344 |
|
| 2000 |
Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Journal of the American College of Cardiology. 36: 1063-70. PMID 10985706 DOI: 10.1016/S0735-1097(00)00879-2 |
0.356 |
|
| 2000 |
Straznicky IT, White HD. Thrombolytic therapy for acute myocardial infarction in the elderly. Coronary Artery Disease. 11: 299-304. PMID 10860172 DOI: 10.1097/00019501-200006000-00002 |
0.312 |
|
| 2000 |
French JK, Hyde TA, Straznicky IT, Andrews J, Lund M, Amos DJ, Zambanini A, Ellis CJ, Webber BJ, McLaughlin SC, Whitlock RM, Manda SO, Patel H, White HD. Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction. Journal of the American College of Cardiology. 35: 1516-24. PMID 10807455 DOI: 10.1016/S0735-1097(00)00577-5 |
0.303 |
|
| 2000 |
Andrews J, Straznicky IT, French JK, Green CL, Maas AC, Lund M, Krucoff MW, White HD. ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. Circulation. 101: 2138-43. PMID 10801752 DOI: 10.1161/01.CIR.101.18.2138 |
0.305 |
|
| 2000 |
Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: Report of the SHOCK trial registry American Journal of Medicine. 108: 374-380. PMID 10759093 DOI: 10.1016/S0002-9343(00)00310-7 |
0.334 |
|
| 2000 |
Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, Gibler WB, Stebbins AL, Cianciolo C, Califf RM, Topol EJ. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. The American Journal of Cardiology. 84: 1281-6. PMID 10614791 DOI: 10.1016/S0002-9149(99)00558-5 |
0.326 |
|
| 2000 |
French J, Hyde T, Wong C, Whitlock R, White H. In acute coronary syndromes patients with ST segment depression have improved late survival following early revascularisation Heart, Lung and Circulation. 9: A100. DOI: 10.1046/J.1443-9506.2000.06425.X |
0.313 |
|
| 2000 |
French J, Andrews J, Manda S, Stewart R, McTigue J, White H. Early ST recovery, infarct artery flow and long-term outcome after acute myocardial infarction Heart, Lung and Circulation. 9: A99. DOI: 10.1046/j.1443-9506.2000.06371.x |
0.32 |
|
| 2000 |
Edwards C, French J, Hyde T, Manda S, Mainuu V, White H. Influence of corrected TIMI frame counts on late survival of patients with acute coronary syndromes without ST-segment elevation Heart, Lung and Circulation. 9: A99. DOI: 10.1046/J.1443-9506.2000.0636X.X |
0.351 |
|
| 1999 |
Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet (London, England). 354: 1757-62. PMID 10577636 DOI: 10.1016/S0140-6736(99)10285-X |
0.311 |
|
| 1999 |
White HD. Newer antiplatelet agents in acute coronary syndromes. American Heart Journal. 138: S570-6. PMID 10577464 DOI: 10.1053/HJ.1999.V138.A102298 |
0.359 |
|
| 1999 |
Kong DF, Topol EJ, Bittl JA, White HD, Théroux P, Hasselblad V, Califf RM. Clinical outcomes of bivalirudin for ischemic heart disease. Circulation. 100: 2049-53. PMID 10562259 DOI: 10.1161/01.CIR.100.20.2049 |
0.382 |
|
| 1999 |
White HD. Future of reperfusion therapy for acute myocardial infarction. Lancet (London, England). 354: 695-7. PMID 10475175 DOI: 10.1016/S0140-6736(99)00263-9 |
0.314 |
|
| 1999 |
Hyde TA, French JK, Wong CK, Straznicky IT, Whitlock RM, White HD. Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression. The American Journal of Cardiology. 84: 379-85. PMID 10468072 DOI: 10.1016/S0002-9149(99)00319-7 |
0.305 |
|
| 1999 |
Mahaffey KW, Granger CB, Sloan MA, Green CL, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. American Heart Journal. 138: 493-9. PMID 10467200 DOI: 10.1016/S0002-8703(99)70152-3 |
0.403 |
|
| 1999 |
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH, Picard MH, Menegus MA, Boland J, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock New England Journal of Medicine. 341: 625-634. PMID 10460813 DOI: 10.1056/NEJM199908263410901 |
0.371 |
|
| 1999 |
White HD. Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction. American Heart Journal. 138: S105-14. PMID 10426868 DOI: 10.1016/S0002-8703(99)70329-7 |
0.396 |
|
| 1999 |
Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. The New England Journal of Medicine. 341: 226-32. PMID 10413734 DOI: 10.1056/NEJM199907223410402 |
0.377 |
|
| 1999 |
French JK, Hyde TA, Patel H, Amos DJ, McLaughlin SC, Webber BJ, White HD. Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks. Journal of the American College of Cardiology. 34: 62-9. PMID 10399993 DOI: 10.1016/S0735-1097(99)00166-7 |
0.302 |
|
| 1999 |
Alexander JH, Granger CB, Sadowski Z, Aylward PE, White HD, Thompson TD, Califf RM, Topol EJ. Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators. American Heart Journal. 137: 799-805. PMID 10220627 DOI: 10.1016/S0002-8703(99)70402-3 |
0.332 |
|
| 1999 |
Puma JA, Sketch MH, Thompson TD, Simes RJ, Morris DC, White HD, Topol EJ, Califf RM. Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. The American Journal of Cardiology. 83: 482-7. PMID 10073847 DOI: 10.1016/S0002-9149(98)00899-6 |
0.355 |
|
| 1999 |
Kleiman NS, Granger CB, White HD, Armstrong P, Ardissino D, de Werf FV, Zoldeyhi P, Thompson TD, Califf RM, Topol EJ. Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion. American Heart Journal. 137: 12-23. PMID 9878932 DOI: 10.1016/S0002-8703(99)70455-2 |
0.392 |
|
| 1999 |
French JK, White HD. Hirudin was superior to heparin in preventing CV death, MI and refractory angina, in patients with unstable angina or MI without ST elevation Evidence-Based Cardiovascular Medicine. 3: 68-69. DOI: 10.1054/EBCM.1999.0223 |
0.308 |
|
| 1998 |
White HD. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial. The American Journal of Cardiology. 82: 57P-62P. PMID 9809893 DOI: 10.1016/S0002-9149(98)00663-8 |
0.36 |
|
| 1998 |
French JK, Ellis CJ, White HD. The corrected TIMI frame count. The new gold standard? Australian and New Zealand Journal of Medicine. 28: 569-73. PMID 9777142 DOI: 10.1111/J.1445-5994.1998.TB02113.X |
0.317 |
|
| 1998 |
White HD, Ellis CJ, French JK, Aylward P. Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study. Australian and New Zealand Journal of Medicine. 28: 551-4. PMID 9777138 DOI: 10.1111/J.1445-5994.1998.TB02109.X |
0.379 |
|
| 1998 |
Metz BK, White HD, Granger CB, Simes RJ, Armstrong PW, Hirsh J, Fuster V, MacAulay CM, Califf RM, Topol EJ. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators. Journal of the American College of Cardiology. 31: 1493-8. PMID 9626825 DOI: 10.1016/S0735-1097(98)00138-7 |
0.379 |
|
| 1998 |
White HD, Van de Werf FJ. Thrombolysis for acute myocardial infarction. Circulation. 97: 1632-46. PMID 9593569 DOI: 10.1161/01.CIR.97.16.1632 |
0.342 |
|
| 1998 |
French JK, Ellis CJ, Webber BJ, Williams BF, Amos DJ, Ramanathan K, Whitlock RM, White HD. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity. The American Journal of Cardiology. 81: 665-71. PMID 9527071 |
0.334 |
|
| 1998 |
Gebel JM, Sila CA, Sloan MA, Granger CB, Mahaffey KW, Weisenberger J, Green CL, White HD, Gore JM, Weaver WD, Califf RM, Topol EJ. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke. 29: 563-9. PMID 9506593 DOI: 10.1161/01.STR.29.3.563 |
0.313 |
|
| 1998 |
Brieger DB, Mak KH, White HD, Kleiman NS, Miller DP, Vahanian A, Ross AM, Califf RM, Topol EJ. Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries. The American Journal of Cardiology. 81: 282-7. PMID 9468068 DOI: 10.1016/S0002-9149(97)00909-0 |
0.361 |
|
| 1998 |
Anderson R, White H, Ohman E, Wagner G, Krucoff M, Armstrong P, Iparraguirre H, Weaver W, Gibler W, Califf R. Resolution of ST-segment elevation 90 minutes after thrombolysis for acute myocardial infarction predicts outcome: a GUSTO-III substudy Journal of the American College of Cardiology. 31: 371. DOI: 10.1016/S0735-1097(98)82254-7 |
0.307 |
|
| 1998 |
Granger C, Van de Wert F, Armstrong P, Simes J, White H, MacAulay C, Califf R, Topol E. Hirudin reduces death and myocardial (RE)infarction at 6-months: follow-up results of the GUSTO IIb trial Journal of the American College of Cardiology. 31: 79. DOI: 10.1016/S0735-1097(98)80991-1 |
0.3 |
|
| 1997 |
Ellis CJ, French JK, White HD. Coronary Artery Patency and Survival in Clinical Trials. Journal of Thrombosis and Thrombolysis. 4: 239-250. PMID 10639265 DOI: 10.1023/A:1008894901473 |
0.377 |
|
| 1997 |
Mahaffey KW, Granger CB, Toth CA, White HD, Stebbins AL, Barbash GI, Vahanian A, Topol EJ, Califf RM. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. Journal of the American College of Cardiology. 30: 1606-10. PMID 9385883 DOI: 10.1016/S0735-1097(97)00394-X |
0.34 |
|
| 1997 |
White HD, Aylward PE, Frey MJ, Adgey AA, Nair R, Hillis WS, Shalev Y, Brown MA, French JK, Collins R, Maraganore J, Adelman B. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation. 96: 2155-61. PMID 9337184 DOI: 10.1161/01.CIR.96.7.2155 |
0.371 |
|
| 1997 |
White HD. Unmet therapeutic needs in the management of acute ischemia. The American Journal of Cardiology. 80: 2B-10B. PMID 9291240 DOI: 10.1016/S0002-9149(97)00571-7 |
0.306 |
|
| 1997 |
Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, Granger CB, Ross AM, Califf RM, Topol EJ. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation. 96: 116-21. PMID 9236425 DOI: 10.1161/01.CIR.96.1.116 |
0.349 |
|
| 1997 |
Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Journal of the American College of Cardiology. 30: 171-9. PMID 9207639 DOI: 10.1016/S0735-1097(97)00118-6 |
0.342 |
|
| 1997 |
Califf RM, Woodlief LH, Harrell FE, Lee KL, White HD, Guerci A, Barbash GI, Simes RJ, Weaver WD, Simoons ML, Topol EJ. Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators. American Heart Journal. 133: 630-9. PMID 9200390 DOI: 10.1016/S0002-8703(97)70164-9 |
0.336 |
|
| 1997 |
White HD. Is heparin of value in the management of acute myocardial infarction? Cardiovascular Drugs and Therapy. 11: 111-9. PMID 9140688 DOI: 10.1023/A:1007776613006 |
0.367 |
|
| 1997 |
Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, Smith JO, Burton JR, McCarthy WF, Califf RM, White HD, Weaver WD, Topol EJ, Ross AM. Gender and acute myocardial infarction: is there a different response to thrombolysis? Journal of the American College of Cardiology. 29: 35-42. PMID 8996292 DOI: 10.1016/S0735-1097(96)00449-4 |
0.34 |
|
| 1996 |
Aylward PE, Wilcox RG, Horgan JH, White HD, Granger CB, Califf RM, Topol EJ. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. Annals of Internal Medicine. 125: 891-900. PMID 8967669 DOI: 10.7326/0003-4819-125-11-199612010-00004 |
0.327 |
|
| 1996 |
White HD, Barbash GI, Califf RM, Simes RJ, Granger CB, Weaver WD, Kleiman NS, Aylward PE, Gore JM, Vahanian A, Lee KL, Ross AM, Topol EJ. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation. 94: 1826-33. PMID 8873656 DOI: 10.1161/01.CIR.94.8.1826 |
0.369 |
|
| 1996 |
Ellis CJ, French JK, White HD. Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarct. Heart (British Cardiac Society). 76: 291. PMID 8868995 DOI: 10.1136/hrt.76.3.291-b |
0.313 |
|
| 1996 |
Califf RM, White HD, Van de Werf F, Sadowski Z, Armstrong PW, Vahanian A, Simoons ML, Simes RJ, Lee KL, Topol EJ. One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. Circulation. 94: 1233-8. PMID 8822974 DOI: 10.1161/01.CIR.94.6.1233 |
0.306 |
|
| 1996 |
French JK, Williams BF, Hart HH, Wyatt S, Poole JE, Ingram C, Ellis CJ, Williams MG, White HD. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Bmj (Clinical Research Ed.). 312: 1637-41. PMID 8664716 DOI: 10.1136/bmj.312.7047.1637 |
0.315 |
|
| 1996 |
Granger CB, Hirsch J, Califf RM, Col J, White HD, Betriu A, Woodlief LH, Lee KL, Bovill EG, Simes RJ, Topol EJ. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation. 93: 870-8. PMID 8598077 DOI: 10.1161/01.CIR.93.5.870 |
0.336 |
|
| 1996 |
Ellis CJ, French JK, Williams BF, Wyatt S, Poole J, Ingram C, Williams MG, Hart HH, White HD. Thrombolytic therapy can be given to half of hospitalized patients with acute myocardial infarction Journal of the American College of Cardiology. 27: 249. DOI: 10.1016/S0735-1097(96)81875-4 |
0.31 |
|
| 1995 |
Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation. 91: 1923-8. PMID 7895348 DOI: 10.1161/01.CIR.91.7.1923 |
0.378 |
|
| 1995 |
White HD, French JK, Hamer AW, Brown MA, Williams BF, Ormiston JA, Cross DB. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. Journal of the American College of Cardiology. 25: 218-23. PMID 7798505 DOI: 10.1016/0735-1097(94)00331-J |
0.315 |
|
| 1995 |
Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, Barbash G, White H, Simoons ML, Nelson CL. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. The New England Journal of Medicine. 332: 1418-24. PMID 7723799 DOI: 10.1056/NEJM199505253322106 |
0.305 |
|
| 1995 |
Karnash SL, Granger CB, White HD, Woodlief LH, Topol EJ, Califf RM. Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial. Journal of the American College of Cardiology. 26: 1651-6. PMID 7594099 DOI: 10.1016/0735-1097(95)00386-X |
0.306 |
|
| 1995 |
Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, Morris D, Aylward P, Woodlief LH, Topol EJ. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. Journal of the American College of Cardiology. 26: 1222-9. PMID 7594035 DOI: 10.1016/0735-1097(95)00299-5 |
0.344 |
|
| 1995 |
Lee HS, Ellis CJ, French JK, White HD, Tobe TJ. Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarction? Heart. 74: 476-478. DOI: 10.1136/hrt.74.4.476-a |
0.313 |
|
| 1994 |
White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation. 89: 61-7. PMID 8281696 DOI: 10.1161/01.CIR.89.1.61 |
0.328 |
|
| 1994 |
Woo KS, White HD. Factors affecting outcome after recovery from myocardial infarction Annual Review of Medicine. 45: 325-339. PMID 8198387 DOI: 10.1146/annurev.med.45.1.325 |
0.325 |
|
| 1994 |
Kleiman NS, White HD, Ohman EM, Ross AM, Woodlief LH, Califf RM, Holmes DR, Bates E, Pfisterer M, Vahanian A. Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Circulation. 90: 2658-65. PMID 7994805 DOI: 10.1161/01.CIR.90.6.2658 |
0.357 |
|
| 1994 |
Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EA, Van der Werf T. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Archives of Internal Medicine. 154: 2237-42. PMID 7944845 DOI: 10.1001/Archinte.1994.00420190141016 |
0.315 |
|
| 1994 |
Woo KS, White HD. Thrombolytic therapy in acute myocardial infarction Current Opinion in Cardiology. 9: 471???482. DOI: 10.1097/00001573-199407000-00010 |
0.314 |
|
| 1993 |
Barbash GI, White HD, Modan M, Van de Werf F. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Journal of the American College of Cardiology. 22: 707-13. PMID 8354802 DOI: 10.1016/0735-1097(93)90180-9 |
0.311 |
|
| 1993 |
Norris RM, White HD, Cross DB, Woo KS, Maslowski AH, Caruana MP, Hart HH, Williams B. Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction. British Heart Journal. 69: 492-5. PMID 8343314 DOI: 10.1136/hrt.69.6.492 |
0.345 |
|
| 1993 |
Norris RM, White HD, Cross DB, Woo KS, Elliott JM, Twigden D, Williams B, Johnson RN. Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis British Heart Journal. 69: 485-491. PMID 8343313 DOI: 10.1136/hrt.69.6.485 |
0.334 |
|
| 1993 |
Norris RM, Twigden DG, Williams BF, Johnson RN, White HD. Use of creatine kinase isoforms for diagnosis of infarct artery patency after thrombolytic therapy with streptokinase Coronary Artery Disease. 4: 201-205. PMID 8269212 DOI: 10.1097/00019501-199302000-00011 |
0.32 |
|
| 1992 |
Barbash GI, White HD, Modan M, Van de Werf F. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Journal of the American College of Cardiology. 20: 36-41. PMID 1607536 DOI: 10.1016/0735-1097(92)90134-9 |
0.326 |
|
| 1992 |
Topol EJ, Armstrong P, Van de Werf F, Kleiman N, Lee K, Morris D, Simoons M, Barbash G, White H, Califf RM. Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering Committee. Journal of the American College of Cardiology. 19: 1123-8. PMID 1564212 DOI: 10.1016/0735-1097(92)90312-B |
0.3 |
|
| 1992 |
Norris RM, Ockelford PA, Cross DB, Rivers JT, Smith JM, Takayama M, White HD. Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction. Australian and New Zealand Journal of Medicine. 22: 261-4. PMID 1497553 DOI: 10.1111/J.1445-5994.1992.TB02122.X |
0.308 |
|
| 1992 |
White HD. Remodelling of the heart after myocardial infarction. Australian and New Zealand Journal of Medicine. 22: 601-6. PMID 1449447 DOI: 10.1111/J.1445-5994.1992.TB00485.X |
0.322 |
|
| 1992 |
Norris RM, White HD, Cross DB, Wild CJ, Whitlock RML. Prognosis after recovery from myocardial infarction: The relative importance of cardiac dilatation and coronary stenoses European Heart Journal. 13: 1611-1618. PMID 1289089 DOI: 10.1093/OXFORDJOURNALS.EURHEARTJ.A060113 |
0.368 |
|
| 1990 |
Norris RM, White HD. Left ventricular function as an end-point of thrombolytic therapy. European Heart Journal. 5-9. PMID 2121490 DOI: 10.1093/EURHEARTJ/11.SUPPL_F.5 |
0.309 |
|
| 1990 |
White HD, Cross DB, Williams BF, Norris RM. Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction. British Heart Journal. 64: 177-81. PMID 2119665 DOI: 10.1136/hrt.64.3.177 |
0.34 |
|
| 1990 |
Rivers JT, White HD, Cross DB, Williams BF, Norris RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. Journal of the American College of Cardiology. 16: 340-8. PMID 2115538 DOI: 10.1016/0735-1097(90)90583-B |
0.343 |
|
| 1988 |
Norris RM, White HD. Thrombolytic therapy for acute myocardial infarction--round 2. Lancet (London, England). 1: 823. PMID 2895338 DOI: 10.1016/S0140-6736(88)91681-9 |
0.315 |
|
| 1987 |
White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 76: 44-51. PMID 3594774 DOI: 10.1161/01.CIR.76.1.44 |
0.325 |
|
| 1987 |
White HD, Norris RM. Thrombolysis: an effective therapy in acute coronary thrombosis. Australian and New Zealand Journal of Medicine. 16: 441-3. PMID 3467688 DOI: 10.1111/J.1445-5994.1986.TB02006.X |
0.339 |
|
| 1987 |
White HD, Norris RM, Brown MA, Takayama M, Maslowski A, Bass NM, Ormiston JA, Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. The New England Journal of Medicine. 317: 850-5. PMID 2888018 DOI: 10.1056/NEJM198710013171402 |
0.323 |
|
| Show low-probability matches. |